JP6155280B2 - フェニルアルキルカルバメート誘導体化合物およびこれを含む薬学組成物 - Google Patents
フェニルアルキルカルバメート誘導体化合物およびこれを含む薬学組成物 Download PDFInfo
- Publication number
- JP6155280B2 JP6155280B2 JP2014549991A JP2014549991A JP6155280B2 JP 6155280 B2 JP6155280 B2 JP 6155280B2 JP 2014549991 A JP2014549991 A JP 2014549991A JP 2014549991 A JP2014549991 A JP 2014549991A JP 6155280 B2 JP6155280 B2 JP 6155280B2
- Authority
- JP
- Japan
- Prior art keywords
- carbamate
- iodophenyl
- methoxymethoxy
- methoxy
- production example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 Phenylalkyl carbamate derivative compound Chemical class 0.000 title claims description 239
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 1097
- 150000001875 compounds Chemical class 0.000 claims description 368
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 147
- 125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 claims description 143
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 88
- 239000000203 mixture Substances 0.000 claims description 66
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 56
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 46
- 150000003839 salts Chemical class 0.000 claims description 43
- ZUHQRBOAKRLOGM-UHFFFAOYSA-N heptylcarbamic acid Chemical compound CCCCCCCNC(O)=O ZUHQRBOAKRLOGM-UHFFFAOYSA-N 0.000 claims description 24
- 206010021118 Hypotonia Diseases 0.000 claims description 22
- 230000036640 muscle relaxation Effects 0.000 claims description 22
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 21
- 201000010099 disease Diseases 0.000 claims description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 20
- 208000007101 Muscle Cramp Diseases 0.000 claims description 19
- 208000005392 Spasm Diseases 0.000 claims description 19
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 claims description 18
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 18
- 239000003158 myorelaxant agent Substances 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 150000002431 hydrogen Chemical class 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 11
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 8
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 6
- 150000002367 halogens Chemical group 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 5
- 206010008025 Cerebellar ataxia Diseases 0.000 claims description 4
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 4
- 208000028994 Spinal vascular disease Diseases 0.000 claims description 4
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims description 4
- 206010008129 cerebral palsy Diseases 0.000 claims description 4
- 208000036319 cervical spondylosis Diseases 0.000 claims description 4
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 208000005801 spondylosis Diseases 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000011737 fluorine Chemical group 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 230000001148 spastic effect Effects 0.000 claims description 3
- 210000000278 spinal cord Anatomy 0.000 claims description 3
- 230000000472 traumatic effect Effects 0.000 claims description 3
- CQPOALVYYNKTBZ-UHFFFAOYSA-N CC(C(C1=CC=CC=C1Cl)N(C)C(=O)O)OC(=O)N Chemical compound CC(C(C1=CC=CC=C1Cl)N(C)C(=O)O)OC(=O)N CQPOALVYYNKTBZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims 3
- 206010033799 Paralysis Diseases 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 208000021090 palsy Diseases 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 description 571
- 238000002360 preparation method Methods 0.000 description 335
- VMBILFRHBQVTOS-IMTBSYHQSA-N (1s,2s)-1-(2-chlorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=CC=C1Cl VMBILFRHBQVTOS-IMTBSYHQSA-N 0.000 description 94
- 229910052717 sulfur Inorganic materials 0.000 description 74
- 238000010898 silica gel chromatography Methods 0.000 description 66
- IGKJZZNHGRQLAI-GORDUTHDSA-N 1-chloro-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC=C1Cl IGKJZZNHGRQLAI-GORDUTHDSA-N 0.000 description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 47
- 238000012360 testing method Methods 0.000 description 33
- 238000006243 chemical reaction Methods 0.000 description 28
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 26
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 24
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 24
- 150000002009 diols Chemical class 0.000 description 23
- JYQYBTAAWXKLEO-IMTBSYHQSA-N (1s,2s)-1-(2-iodophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=CC=C1I JYQYBTAAWXKLEO-IMTBSYHQSA-N 0.000 description 22
- 239000012044 organic layer Substances 0.000 description 19
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 238000000034 method Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- PNNICJNBEJUSCX-UWVGGRQHSA-N (1s,2s)-1-(2-iodophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=CC=CC=C1I PNNICJNBEJUSCX-UWVGGRQHSA-N 0.000 description 12
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 12
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 11
- 239000001294 propane Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 0 *C(c1ccccc1)=O Chemical compound *C(c1ccccc1)=O 0.000 description 10
- 229940083957 1,2-butanediol Drugs 0.000 description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 10
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 10
- ZWDVQMVZZYIAHO-UHFFFAOYSA-N 2-fluorobenzaldehyde Chemical compound FC1=CC=CC=C1C=O ZWDVQMVZZYIAHO-UHFFFAOYSA-N 0.000 description 9
- WWKKTHALZAYYAI-UHFFFAOYSA-N 2-iodobenzaldehyde Chemical compound IC1=CC=CC=C1C=O WWKKTHALZAYYAI-UHFFFAOYSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 8
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- OXKFWPPHXWNDOW-GORDUTHDSA-N 1-iodo-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC=C1I OXKFWPPHXWNDOW-GORDUTHDSA-N 0.000 description 7
- GINRWRINOAPPOO-NSCUHMNNSA-N 2,4-dichloro-1-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=C(Cl)C=C1Cl GINRWRINOAPPOO-NSCUHMNNSA-N 0.000 description 7
- 210000003169 central nervous system Anatomy 0.000 description 7
- WIVQZMYXMZGRTP-HWKANZROSA-N 1-[(e)-but-1-enyl]-3-iodobenzene Chemical compound CC\C=C\C1=CC=CC(I)=C1 WIVQZMYXMZGRTP-HWKANZROSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 6
- 239000001273 butane Substances 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- QFPQLZHUGOUPQK-RYUDHWBXSA-N (1s,2s)-1-(2-iodophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=CC=CC=C1I QFPQLZHUGOUPQK-RYUDHWBXSA-N 0.000 description 5
- QPRIVKPLQATOSC-VMPITWQZSA-N 1-[(e)-hex-1-enyl]-2-iodobenzene Chemical compound CCCC\C=C\C1=CC=CC=C1I QPRIVKPLQATOSC-VMPITWQZSA-N 0.000 description 5
- MVDNHEJQHPNYRA-FNORWQNLSA-N 1-[(e)-hex-1-enyl]-3-iodobenzene Chemical compound CCCC\C=C\C1=CC=CC(I)=C1 MVDNHEJQHPNYRA-FNORWQNLSA-N 0.000 description 5
- JVSDDCBODITJKV-DUXPYHPUSA-N 1-iodo-3-[(E)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC(I)=C1 JVSDDCBODITJKV-DUXPYHPUSA-N 0.000 description 5
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- MMXIWYKJTHNEPP-DUXPYHPUSA-N 1,2-dichloro-3-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC(Cl)=C1Cl MMXIWYKJTHNEPP-DUXPYHPUSA-N 0.000 description 4
- SFNMUSXQNVVSQF-FNORWQNLSA-N 1,3-dichloro-2-[(e)-hex-1-enyl]benzene Chemical compound CCCC\C=C\C1=C(Cl)C=CC=C1Cl SFNMUSXQNVVSQF-FNORWQNLSA-N 0.000 description 4
- OXKLFARWXRFSJF-DUXPYHPUSA-N 1,3-dichloro-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=C(Cl)C=CC=C1Cl OXKLFARWXRFSJF-DUXPYHPUSA-N 0.000 description 4
- AZRRPQWGXBUAHZ-ONEGZZNKSA-N 1-[(e)-but-1-enyl]-2,4-dichlorobenzene Chemical compound CC\C=C\C1=CC=C(Cl)C=C1Cl AZRRPQWGXBUAHZ-ONEGZZNKSA-N 0.000 description 4
- KHJTVYHLGNOTFZ-ZZXKWVIFSA-N 1-[(e)-but-1-enyl]-2-chlorobenzene Chemical compound CC\C=C\C1=CC=CC=C1Cl KHJTVYHLGNOTFZ-ZZXKWVIFSA-N 0.000 description 4
- PYKMMDKUSXTOLD-ZZXKWVIFSA-N 1-[(e)-but-1-enyl]-2-iodobenzene Chemical compound CC\C=C\C1=CC=CC=C1I PYKMMDKUSXTOLD-ZZXKWVIFSA-N 0.000 description 4
- PCNJFVMNGSKYMS-VMPITWQZSA-N 1-chloro-2-[(e)-hex-1-enyl]benzene Chemical compound CCCC\C=C\C1=CC=CC=C1Cl PCNJFVMNGSKYMS-VMPITWQZSA-N 0.000 description 4
- JEAVUZSNGJBETR-VOTSOKGWSA-N 1-iodo-3-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=CC(I)=C1 JEAVUZSNGJBETR-VOTSOKGWSA-N 0.000 description 4
- LNFPJUUVEYZDRI-HWKANZROSA-N 2-[(e)-but-1-enyl]-1,3-dichlorobenzene Chemical compound CC\C=C\C1=C(Cl)C=CC=C1Cl LNFPJUUVEYZDRI-HWKANZROSA-N 0.000 description 4
- RZODAQZAFOBFLS-UHFFFAOYSA-N 3-iodobenzaldehyde Chemical compound IC1=CC=CC(C=O)=C1 RZODAQZAFOBFLS-UHFFFAOYSA-N 0.000 description 4
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- LNGFFOVVYWDHCT-CWSLVUQWSA-N [(1R,2R)-2-(2-chlorophenyl)cyclohexyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@@H]1CCCC[C@@H]1C1=CC=CC=C1Cl LNGFFOVVYWDHCT-CWSLVUQWSA-N 0.000 description 4
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 4
- 125000001033 ether group Chemical group 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000007911 parenteral administration Methods 0.000 description 4
- 210000003200 peritoneal cavity Anatomy 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- IEJVWZLNGLISLX-UWVGGRQHSA-N (1s,2s)-1-(2,4-dichlorophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=CC=C(Cl)C=C1Cl IEJVWZLNGLISLX-UWVGGRQHSA-N 0.000 description 3
- ZJHXADRDRNHFRO-SSDLBLMSSA-N (1s,2s)-1-(2,6-dichlorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=C(Cl)C=CC=C1Cl ZJHXADRDRNHFRO-SSDLBLMSSA-N 0.000 description 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 3
- QBPBVAWBQXFHFY-VOTSOKGWSA-N 1,3-dichloro-2-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=C(Cl)C=CC=C1Cl QBPBVAWBQXFHFY-VOTSOKGWSA-N 0.000 description 3
- BDIVPQHPHFRKQM-NSCUHMNNSA-N 1,4-dichloro-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC(Cl)=CC=C1Cl BDIVPQHPHFRKQM-NSCUHMNNSA-N 0.000 description 3
- FPGCYTJCZNIGCD-ONEGZZNKSA-N 1-[(e)-but-1-enyl]-4-fluorobenzene Chemical compound CC\C=C\C1=CC=C(F)C=C1 FPGCYTJCZNIGCD-ONEGZZNKSA-N 0.000 description 3
- XIRQZNRAMUICFS-BQYQJAHWSA-N 1-chloro-2-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=CC=C1Cl XIRQZNRAMUICFS-BQYQJAHWSA-N 0.000 description 3
- XTTXFZCFQZQUME-GORDUTHDSA-N 1-fluoro-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC=C1F XTTXFZCFQZQUME-GORDUTHDSA-N 0.000 description 3
- KEIMWCURMAEHNU-ONEGZZNKSA-N 1-fluoro-4-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=C(F)C=C1 KEIMWCURMAEHNU-ONEGZZNKSA-N 0.000 description 3
- HNIVDZHQAQXMQX-AATRIKPKSA-N 1-fluoro-4-[(e)-hex-1-enyl]benzene Chemical compound CCCC\C=C\C1=CC=C(F)C=C1 HNIVDZHQAQXMQX-AATRIKPKSA-N 0.000 description 3
- ISSQWNWNKKUUAA-NSCUHMNNSA-N 1-fluoro-4-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=C(F)C=C1 ISSQWNWNKKUUAA-NSCUHMNNSA-N 0.000 description 3
- ACUGAGLDFIVSBR-UHFFFAOYSA-N 2,6-dimethylheptan-4-one Chemical compound CC(C)CC(=O)CC(C)C.CC(C)CC(=O)CC(C)C ACUGAGLDFIVSBR-UHFFFAOYSA-N 0.000 description 3
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 3
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 3
- ZPQAKYPOZRXKFA-UHFFFAOYSA-N 6-Undecanone Chemical compound CCCCCC(=O)CCCCC ZPQAKYPOZRXKFA-UHFFFAOYSA-N 0.000 description 3
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XXKZCJULNHLLBW-YLGOGADGSA-N CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2F)OCOC Chemical compound CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2F)OCOC XXKZCJULNHLLBW-YLGOGADGSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- JEPPYVOSGKWVSJ-UHFFFAOYSA-N bicyclo[2.2.1]heptan-3-amine Chemical compound C1CC2C(N)CC1C2 JEPPYVOSGKWVSJ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- FLKWPERUUCNAAU-ANLVUFKYSA-N (1r,2r)-1-(2,3-dichlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC(Cl)=C1Cl FLKWPERUUCNAAU-ANLVUFKYSA-N 0.000 description 2
- IEJVWZLNGLISLX-NXEZZACHSA-N (1r,2r)-1-(2,4-dichlorophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=CC=C(Cl)C=C1Cl IEJVWZLNGLISLX-NXEZZACHSA-N 0.000 description 2
- FGJGOWLECMAOBT-VXGBXAGGSA-N (1r,2r)-1-(2,4-dichlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=CC=C(Cl)C=C1Cl FGJGOWLECMAOBT-VXGBXAGGSA-N 0.000 description 2
- SCSAPYIJZGZEAX-ANLVUFKYSA-N (1r,2r)-1-(2,4-dichlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=C(Cl)C=C1Cl SCSAPYIJZGZEAX-ANLVUFKYSA-N 0.000 description 2
- PBNHKZMJUSOMKF-SCZZXKLOSA-N (1r,2r)-1-(2,6-dichlorophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=C(Cl)C=CC=C1Cl PBNHKZMJUSOMKF-SCZZXKLOSA-N 0.000 description 2
- GASSOTNCOMXJIO-PWSUYJOCSA-N (1r,2r)-1-(2,6-dichlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=C(Cl)C=CC=C1Cl GASSOTNCOMXJIO-PWSUYJOCSA-N 0.000 description 2
- ZJHXADRDRNHFRO-ANLVUFKYSA-N (1r,2r)-1-(2,6-dichlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=C(Cl)C=CC=C1Cl ZJHXADRDRNHFRO-ANLVUFKYSA-N 0.000 description 2
- SJJUIBIYAYKJNV-NXEZZACHSA-N (1r,2r)-1-(2-chlorophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=CC=CC=C1Cl SJJUIBIYAYKJNV-NXEZZACHSA-N 0.000 description 2
- RWOIZSMJTJMYDY-VXGBXAGGSA-N (1r,2r)-1-(2-chlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=CC=CC=C1Cl RWOIZSMJTJMYDY-VXGBXAGGSA-N 0.000 description 2
- VMBILFRHBQVTOS-MUWHJKNJSA-N (1r,2r)-1-(2-chlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC=C1Cl VMBILFRHBQVTOS-MUWHJKNJSA-N 0.000 description 2
- ZBCGRRLGXMTHGN-MUWHJKNJSA-N (1r,2r)-1-(2-fluorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC=C1F ZBCGRRLGXMTHGN-MUWHJKNJSA-N 0.000 description 2
- QJKLVJHTAXEGBE-GHMZBOCLSA-N (1r,2r)-1-(2-iodophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@@H](O)[C@H](O)C1=CC=CC=C1I QJKLVJHTAXEGBE-GHMZBOCLSA-N 0.000 description 2
- JYQYBTAAWXKLEO-MUWHJKNJSA-N (1r,2r)-1-(2-iodophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC=C1I JYQYBTAAWXKLEO-MUWHJKNJSA-N 0.000 description 2
- FLKWPERUUCNAAU-SSDLBLMSSA-N (1s,2s)-1-(2,3-dichlorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=CC(Cl)=C1Cl FLKWPERUUCNAAU-SSDLBLMSSA-N 0.000 description 2
- FGJGOWLECMAOBT-RYUDHWBXSA-N (1s,2s)-1-(2,4-dichlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=CC=C(Cl)C=C1Cl FGJGOWLECMAOBT-RYUDHWBXSA-N 0.000 description 2
- SCSAPYIJZGZEAX-SSDLBLMSSA-N (1s,2s)-1-(2,4-dichlorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=C(Cl)C=C1Cl SCSAPYIJZGZEAX-SSDLBLMSSA-N 0.000 description 2
- PBNHKZMJUSOMKF-WCBMZHEXSA-N (1s,2s)-1-(2,6-dichlorophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=C(Cl)C=CC=C1Cl PBNHKZMJUSOMKF-WCBMZHEXSA-N 0.000 description 2
- GASSOTNCOMXJIO-CMPLNLGQSA-N (1s,2s)-1-(2,6-dichlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=C(Cl)C=CC=C1Cl GASSOTNCOMXJIO-CMPLNLGQSA-N 0.000 description 2
- SJJUIBIYAYKJNV-UWVGGRQHSA-N (1s,2s)-1-(2-chlorophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=CC=CC=C1Cl SJJUIBIYAYKJNV-UWVGGRQHSA-N 0.000 description 2
- RWOIZSMJTJMYDY-RYUDHWBXSA-N (1s,2s)-1-(2-chlorophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=CC=CC=C1Cl RWOIZSMJTJMYDY-RYUDHWBXSA-N 0.000 description 2
- ZBCGRRLGXMTHGN-IMTBSYHQSA-N (1s,2s)-1-(2-fluorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=CC=C1F ZBCGRRLGXMTHGN-IMTBSYHQSA-N 0.000 description 2
- QJKLVJHTAXEGBE-QWRGUYRKSA-N (1s,2s)-1-(2-iodophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=CC=CC=C1I QJKLVJHTAXEGBE-QWRGUYRKSA-N 0.000 description 2
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 2
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 2
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 2
- KEPKZMCEWNJASR-DUXPYHPUSA-N 1,3-difluoro-2-[(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=C(F)C=CC=C1F KEPKZMCEWNJASR-DUXPYHPUSA-N 0.000 description 2
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 2
- XWOXMTYADWQNHO-UHFFFAOYSA-N 1-(2,5-dichlorophenyl)propane-1,2-diol Chemical compound CC(O)C(O)C1=CC(Cl)=CC=C1Cl XWOXMTYADWQNHO-UHFFFAOYSA-N 0.000 description 2
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 2
- YSNQDXUVWKGVFO-ZZXKWVIFSA-N 1-[(e)-but-1-enyl]-2-fluorobenzene Chemical compound CC\C=C\C1=CC=CC=C1F YSNQDXUVWKGVFO-ZZXKWVIFSA-N 0.000 description 2
- YNQXOOPPJWSXMW-UHFFFAOYSA-N 1-ethenyl-2-fluorobenzene Chemical compound FC1=CC=CC=C1C=C YNQXOOPPJWSXMW-UHFFFAOYSA-N 0.000 description 2
- PSIKFNDJOGHVHP-UHFFFAOYSA-N 1-ethenyl-2-iodobenzene Chemical compound IC1=CC=CC=C1C=C PSIKFNDJOGHVHP-UHFFFAOYSA-N 0.000 description 2
- WFYHQXHFQVUNDN-BQYQJAHWSA-N 1-iodo-2-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=CC=C1I WFYHQXHFQVUNDN-BQYQJAHWSA-N 0.000 description 2
- IBMUHJIDXFMZPI-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O.ClC1=CC=CC=C1C=O IBMUHJIDXFMZPI-UHFFFAOYSA-N 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 2
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 2
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 2
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 2
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 2
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 2
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VBCAHIMPOUMLTF-GHFFVFNYSA-N CC(C)CC([C@H]1CCCC[C@@H]1OC(=O)N)(C2=CC=CC=C2I)OC Chemical compound CC(C)CC([C@H]1CCCC[C@@H]1OC(=O)N)(C2=CC=CC=C2I)OC VBCAHIMPOUMLTF-GHFFVFNYSA-N 0.000 description 2
- ZEHITMQBFDRLTP-WWKKGYIRSA-N CC(C)CC([C@H]1CCCC[C@@H]1OC(=O)N)(C2=CC=CC=C2I)OCOC Chemical compound CC(C)CC([C@H]1CCCC[C@@H]1OC(=O)N)(C2=CC=CC=C2I)OCOC ZEHITMQBFDRLTP-WWKKGYIRSA-N 0.000 description 2
- YNCOOSAZFXQCOG-DMJNXXHZSA-N CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O YNCOOSAZFXQCOG-DMJNXXHZSA-N 0.000 description 2
- JNFKWFXZUDZVAX-WOEZKJSCSA-N CCC([C@@]1(CCCC[C@H]1OC(=O)N)C2=CC=CC=C2Cl)OCOC Chemical compound CCC([C@@]1(CCCC[C@H]1OC(=O)N)C2=CC=CC=C2Cl)OCOC JNFKWFXZUDZVAX-WOEZKJSCSA-N 0.000 description 2
- JTLXRFKYQSDEHJ-ROQRJRBISA-N CCC([C@]1(CC2CC[C@@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OC Chemical compound CCC([C@]1(CC2CC[C@@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OC JTLXRFKYQSDEHJ-ROQRJRBISA-N 0.000 description 2
- JNFKWFXZUDZVAX-YLGOGADGSA-N CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2Cl)OCOC Chemical compound CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2Cl)OCOC JNFKWFXZUDZVAX-YLGOGADGSA-N 0.000 description 2
- CDTASRGKXHETTC-ZWBSKUQPSA-N CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC Chemical compound CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC CDTASRGKXHETTC-ZWBSKUQPSA-N 0.000 description 2
- FLJMIKJBSVOJGX-YLGOGADGSA-N CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC Chemical compound CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC FLJMIKJBSVOJGX-YLGOGADGSA-N 0.000 description 2
- IITWDWPCVOMEQI-YLGOGADGSA-N CCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC Chemical compound CCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC IITWDWPCVOMEQI-YLGOGADGSA-N 0.000 description 2
- SHFGRWIYXVIRMG-SJQFFEKCSA-N CCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC Chemical compound CCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC SHFGRWIYXVIRMG-SJQFFEKCSA-N 0.000 description 2
- MJJAVHGLIWPYNC-WSTRIDTPSA-N CCCCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC Chemical compound CCCCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OC MJJAVHGLIWPYNC-WSTRIDTPSA-N 0.000 description 2
- CZXBINKTJDFLCN-ZDZADGERSA-N CCCCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC Chemical compound CCCCCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2I)OCOC CZXBINKTJDFLCN-ZDZADGERSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical class NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019196 Head injury Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 206010049816 Muscle tightness Diseases 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 2
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 2
- 206010041415 Spastic paralysis Diseases 0.000 description 2
- 206010057268 Spinal cord paralysis Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- PRWNGPAGJVGFAJ-LLXLYJOTSA-N [(1R,2R)-1-(2-chlorophenyl)-2-[1-(methoxymethoxy)propyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@]1(CC2CC[C@@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OCOC PRWNGPAGJVGFAJ-LLXLYJOTSA-N 0.000 description 2
- CFUKUKNHSVTRDA-IYNBXCLQSA-N [(1R,2R)-2-(2-chlorophenyl)cyclohexyl]-[1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCOC(CC)N(C(O)=O)[C@@H]1CCCC[C@@H]1C1=CC=CC=C1Cl CFUKUKNHSVTRDA-IYNBXCLQSA-N 0.000 description 2
- STWAEMYMXIXAHP-HLVWMGJTSA-N [(1R,2R)-2-(2-chlorophenyl)cyclopropyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@@H]1C[C@@H]1C1=CC=CC=C1Cl STWAEMYMXIXAHP-HLVWMGJTSA-N 0.000 description 2
- CUUDTYKUXFZHOX-AYBZEELNSA-N [(1R,2R)-2-(2-chlorophenyl)cyclopropyl]-[1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCOC(CC)N(C(O)=O)[C@@H]1C[C@@H]1C1=CC=CC=C1Cl CUUDTYKUXFZHOX-AYBZEELNSA-N 0.000 description 2
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 2
- HVFPQONMEHRNGY-BXUZGUMPSA-N [(2R)-1-(2-chlorophenyl)propan-2-yl]-[(1R)-1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCO[C@H](CC)N(C(O)=O)[C@H](C)CC1=CC=CC=C1Cl HVFPQONMEHRNGY-BXUZGUMPSA-N 0.000 description 2
- ZDLPJFDFZWWSGI-ZWNOBZJWSA-N [(2R)-1-(2-chlorophenyl)propan-2-yl]-[(1R)-1-methoxypropyl]carbamic acid Chemical compound CC[C@@H](OC)N(C(O)=O)[C@H](C)CC1=CC=CC=C1Cl ZDLPJFDFZWWSGI-ZWNOBZJWSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000005821 brain abnormality Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000004744 fore-foot Anatomy 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 2
- ZMPGBVQQIQSQED-MRVPVSSYSA-N methyl (2r)-2-(2-chlorophenyl)-2-hydroxyacetate Chemical compound COC(=O)[C@H](O)C1=CC=CC=C1Cl ZMPGBVQQIQSQED-MRVPVSSYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 230000004220 muscle function Effects 0.000 description 2
- 229940035363 muscle relaxants Drugs 0.000 description 2
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 2
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 2
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical class [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- XKXIQBVKMABYQJ-UHFFFAOYSA-M tert-butyl carbonate Chemical compound CC(C)(C)OC([O-])=O XKXIQBVKMABYQJ-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- YKJQBLADLFGEHN-NSHDSACASA-N (1r)-1-(2-chlorophenyl)-1-(methoxymethoxy)propan-2-one Chemical compound COCO[C@@H](C(C)=O)C1=CC=CC=C1Cl YKJQBLADLFGEHN-NSHDSACASA-N 0.000 description 1
- XWOXMTYADWQNHO-ANLVUFKYSA-N (1r,2r)-1-(2,5-dichlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC(Cl)=CC=C1Cl XWOXMTYADWQNHO-ANLVUFKYSA-N 0.000 description 1
- PNNICJNBEJUSCX-NXEZZACHSA-N (1r,2r)-1-(2-iodophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=CC=CC=C1I PNNICJNBEJUSCX-NXEZZACHSA-N 0.000 description 1
- QFPQLZHUGOUPQK-VXGBXAGGSA-N (1r,2r)-1-(2-iodophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=CC=CC=C1I QFPQLZHUGOUPQK-VXGBXAGGSA-N 0.000 description 1
- RYWDNYZQWHKFKI-GHMZBOCLSA-N (1r,2r)-1-(3-fluorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@@H](O)[C@H](O)C1=CC=CC(F)=C1 RYWDNYZQWHKFKI-GHMZBOCLSA-N 0.000 description 1
- LHBBKBIYPVHBTG-NXEZZACHSA-N (1r,2r)-1-(3-fluorophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=CC=CC(F)=C1 LHBBKBIYPVHBTG-NXEZZACHSA-N 0.000 description 1
- VJLVJWZTUZFJTN-VXGBXAGGSA-N (1r,2r)-1-(3-fluorophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=CC=CC(F)=C1 VJLVJWZTUZFJTN-VXGBXAGGSA-N 0.000 description 1
- DNJDWQHYTHRVAX-MUWHJKNJSA-N (1r,2r)-1-(3-fluorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC(F)=C1 DNJDWQHYTHRVAX-MUWHJKNJSA-N 0.000 description 1
- RFAYOCWNHRYRHP-NXEZZACHSA-N (1r,2r)-1-(3-iodophenyl)butane-1,2-diol Chemical compound CC[C@@H](O)[C@H](O)C1=CC=CC(I)=C1 RFAYOCWNHRYRHP-NXEZZACHSA-N 0.000 description 1
- SYZCPZRXRAZNQK-VXGBXAGGSA-N (1r,2r)-1-(3-iodophenyl)hexane-1,2-diol Chemical compound CCCC[C@@H](O)[C@H](O)C1=CC=CC(I)=C1 SYZCPZRXRAZNQK-VXGBXAGGSA-N 0.000 description 1
- YLIOHAUNZCFZDE-MUWHJKNJSA-N (1r,2r)-1-(3-iodophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@H](O)C1=CC=CC(I)=C1 YLIOHAUNZCFZDE-MUWHJKNJSA-N 0.000 description 1
- VMBILFRHBQVTOS-HZGVNTEJSA-N (1s,2r)-1-(2-chlorophenyl)propane-1,2-diol Chemical compound C[C@@H](O)[C@@H](O)C1=CC=CC=C1Cl VMBILFRHBQVTOS-HZGVNTEJSA-N 0.000 description 1
- KTXUAMHLFGHMKF-QWRGUYRKSA-N (1s,2s)-1-(2,4-dichlorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=CC=C(Cl)C=C1Cl KTXUAMHLFGHMKF-QWRGUYRKSA-N 0.000 description 1
- XWOXMTYADWQNHO-SSDLBLMSSA-N (1s,2s)-1-(2,5-dichlorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC(Cl)=CC=C1Cl XWOXMTYADWQNHO-SSDLBLMSSA-N 0.000 description 1
- DEGHLPBMYKOCEA-QWRGUYRKSA-N (1s,2s)-1-(2,6-dichlorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=C(Cl)C=CC=C1Cl DEGHLPBMYKOCEA-QWRGUYRKSA-N 0.000 description 1
- KRCSSGYHNCYFIT-SSDLBLMSSA-N (1s,2s)-1-(2,6-difluorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=C(F)C=CC=C1F KRCSSGYHNCYFIT-SSDLBLMSSA-N 0.000 description 1
- UNKVUTTUFVDMRK-QWRGUYRKSA-N (1s,2s)-1-(2-chlorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=CC=CC=C1Cl UNKVUTTUFVDMRK-QWRGUYRKSA-N 0.000 description 1
- CLYQZBMXTCJKAM-QWRGUYRKSA-N (1s,2s)-1-(3-iodophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=CC=CC(I)=C1 CLYQZBMXTCJKAM-QWRGUYRKSA-N 0.000 description 1
- RFAYOCWNHRYRHP-UWVGGRQHSA-N (1s,2s)-1-(3-iodophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=CC=CC(I)=C1 RFAYOCWNHRYRHP-UWVGGRQHSA-N 0.000 description 1
- SYZCPZRXRAZNQK-RYUDHWBXSA-N (1s,2s)-1-(3-iodophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=CC=CC(I)=C1 SYZCPZRXRAZNQK-RYUDHWBXSA-N 0.000 description 1
- YLIOHAUNZCFZDE-IMTBSYHQSA-N (1s,2s)-1-(3-iodophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=CC(I)=C1 YLIOHAUNZCFZDE-IMTBSYHQSA-N 0.000 description 1
- JYLFUNWZTRJWOH-QWRGUYRKSA-N (1s,2s)-1-(4-fluorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)[C@H](O)[C@@H](O)C1=CC=C(F)C=C1 JYLFUNWZTRJWOH-QWRGUYRKSA-N 0.000 description 1
- ZFTZLVDPGQTBIY-UWVGGRQHSA-N (1s,2s)-1-(4-fluorophenyl)butane-1,2-diol Chemical compound CC[C@H](O)[C@@H](O)C1=CC=C(F)C=C1 ZFTZLVDPGQTBIY-UWVGGRQHSA-N 0.000 description 1
- NFQVMAGWIFFHKI-RYUDHWBXSA-N (1s,2s)-1-(4-fluorophenyl)hexane-1,2-diol Chemical compound CCCC[C@H](O)[C@@H](O)C1=CC=C(F)C=C1 NFQVMAGWIFFHKI-RYUDHWBXSA-N 0.000 description 1
- LZRDVYWKYXGDNE-IMTBSYHQSA-N (1s,2s)-1-(4-fluorophenyl)propane-1,2-diol Chemical compound C[C@H](O)[C@@H](O)C1=CC=C(F)C=C1 LZRDVYWKYXGDNE-IMTBSYHQSA-N 0.000 description 1
- WZCXOBMFBKSSFA-UHFFFAOYSA-N (2-iodophenyl)methanol Chemical compound OCC1=CC=CC=C1I WZCXOBMFBKSSFA-UHFFFAOYSA-N 0.000 description 1
- FPVVJIAMWVZJGC-VGMFFHCQSA-N (2S)-2-(2-chlorophenyl)-2-hydroxyacetic acid Chemical compound O[C@H](C(O)=O)c1ccccc1Cl.O[C@H](C(O)=O)c1ccccc1Cl FPVVJIAMWVZJGC-VGMFFHCQSA-N 0.000 description 1
- RWOLDZZTBNYTMS-SSDOTTSWSA-N (2r)-2-(2-chlorophenyl)-2-hydroxyacetic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1Cl RWOLDZZTBNYTMS-SSDOTTSWSA-N 0.000 description 1
- NTILMWNUDQTINW-LLVKDONJSA-N (2r)-2-(2-chlorophenyl)-n-methoxy-2-(methoxymethoxy)-n-methylacetamide Chemical compound COCO[C@@H](C(=O)N(C)OC)C1=CC=CC=C1Cl NTILMWNUDQTINW-LLVKDONJSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- FLKWPERUUCNAAU-UHFFFAOYSA-N 1-(2,3-dichlorophenyl)propane-1,2-diol Chemical compound CC(O)C(O)C1=CC=CC(Cl)=C1Cl FLKWPERUUCNAAU-UHFFFAOYSA-N 0.000 description 1
- IEJVWZLNGLISLX-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)butane-1,2-diol Chemical compound CCC(O)C(O)C1=CC=C(Cl)C=C1Cl IEJVWZLNGLISLX-UHFFFAOYSA-N 0.000 description 1
- SCSAPYIJZGZEAX-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)propane-1,2-diol Chemical compound CC(O)C(O)C1=CC=C(Cl)C=C1Cl SCSAPYIJZGZEAX-UHFFFAOYSA-N 0.000 description 1
- PBNHKZMJUSOMKF-UHFFFAOYSA-N 1-(2,6-dichlorophenyl)butane-1,2-diol Chemical compound CCC(O)C(O)C1=C(Cl)C=CC=C1Cl PBNHKZMJUSOMKF-UHFFFAOYSA-N 0.000 description 1
- GASSOTNCOMXJIO-UHFFFAOYSA-N 1-(2,6-dichlorophenyl)hexane-1,2-diol Chemical compound CCCCC(O)C(O)C1=C(Cl)C=CC=C1Cl GASSOTNCOMXJIO-UHFFFAOYSA-N 0.000 description 1
- ZJHXADRDRNHFRO-UHFFFAOYSA-N 1-(2,6-dichlorophenyl)propane-1,2-diol Chemical compound CC(O)C(O)C1=C(Cl)C=CC=C1Cl ZJHXADRDRNHFRO-UHFFFAOYSA-N 0.000 description 1
- KRCSSGYHNCYFIT-UHFFFAOYSA-N 1-(2,6-difluorophenyl)propane-1,2-diol Chemical compound CC(O)C(O)C1=C(F)C=CC=C1F KRCSSGYHNCYFIT-UHFFFAOYSA-N 0.000 description 1
- UNKVUTTUFVDMRK-UHFFFAOYSA-N 1-(2-chlorophenyl)-3-methylbutane-1,2-diol Chemical compound CC(C)C(O)C(O)C1=CC=CC=C1Cl UNKVUTTUFVDMRK-UHFFFAOYSA-N 0.000 description 1
- SJJUIBIYAYKJNV-UHFFFAOYSA-N 1-(2-chlorophenyl)butane-1,2-diol Chemical compound CCC(O)C(O)C1=CC=CC=C1Cl SJJUIBIYAYKJNV-UHFFFAOYSA-N 0.000 description 1
- RWOIZSMJTJMYDY-UHFFFAOYSA-N 1-(2-chlorophenyl)hexane-1,2-diol Chemical compound CCCCC(O)C(O)C1=CC=CC=C1Cl RWOIZSMJTJMYDY-UHFFFAOYSA-N 0.000 description 1
- SQUNAWUMZGQQJD-UHFFFAOYSA-N 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one Chemical compound C1=CC(CC)=CC=C1C(=O)C(C)CN1CCCCC1 SQUNAWUMZGQQJD-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- ARDGXZQSVCPRHC-BQYQJAHWSA-N 1-fluoro-2-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=CC=C1F ARDGXZQSVCPRHC-BQYQJAHWSA-N 0.000 description 1
- IQRPTPQFTXIREV-VMPITWQZSA-N 1-fluoro-2-[(e)-hex-1-enyl]benzene Chemical compound CCCC\C=C\C1=CC=CC=C1F IQRPTPQFTXIREV-VMPITWQZSA-N 0.000 description 1
- YCGUMWLVOZJBJL-JFXOEICMSA-N 1-hydroxybutyl-[(1S,2S)-2-(2-iodophenyl)cyclohexyl]carbamic acid Chemical compound CCCC(N([C@H]1CCCC[C@H]1C2=CC=CC=C2I)C(=O)O)O YCGUMWLVOZJBJL-JFXOEICMSA-N 0.000 description 1
- IRYLQDQHKNTSJO-QDYONFDCSA-N 1-hydroxybutyl-[(1S,2S)-2-(2-iodophenyl)cyclopropyl]carbamic acid Chemical compound CCCC(O)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I IRYLQDQHKNTSJO-QDYONFDCSA-N 0.000 description 1
- YGBVMRMUYWQEEJ-XRJCJLGXSA-N 1-hydroxyhexyl-[(1S,2S)-2-(2-iodophenyl)cyclopropyl]carbamic acid Chemical compound CCCCCC(O)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I YGBVMRMUYWQEEJ-XRJCJLGXSA-N 0.000 description 1
- GPAWRCZZVHHIOM-HFLPBZFISA-N 1-hydroxypropyl-[(1S,2S)-2-(2-iodophenyl)cyclopropyl]carbamic acid Chemical compound CCC(O)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I GPAWRCZZVHHIOM-HFLPBZFISA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- DCNVZMHJVLWARA-ONEGZZNKSA-N 2,4-dichloro-1-[(e)-3-methylbut-1-enyl]benzene Chemical compound CC(C)\C=C\C1=CC=C(Cl)C=C1Cl DCNVZMHJVLWARA-ONEGZZNKSA-N 0.000 description 1
- BMRKPMHGQDHJBI-AATRIKPKSA-N 2,4-dichloro-1-[(e)-hex-1-enyl]benzene Chemical compound CCCC\C=C\C1=CC=C(Cl)C=C1Cl BMRKPMHGQDHJBI-AATRIKPKSA-N 0.000 description 1
- YSFBEAASFUWWHU-UHFFFAOYSA-N 2,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C(Cl)=C1 YSFBEAASFUWWHU-UHFFFAOYSA-N 0.000 description 1
- BUXHYMZMVMNDMG-UHFFFAOYSA-N 2,5-dichlorobenzaldehyde Chemical compound ClC1=CC=C(Cl)C(C=O)=C1 BUXHYMZMVMNDMG-UHFFFAOYSA-N 0.000 description 1
- SOWRUJSGHKNOKN-UHFFFAOYSA-N 2,6-difluorobenzaldehyde Chemical compound FC1=CC=CC(F)=C1C=O SOWRUJSGHKNOKN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 1
- ISRGONDNXBCDBM-UHFFFAOYSA-N 2-chlorostyrene Chemical compound ClC1=CC=CC=C1C=C ISRGONDNXBCDBM-UHFFFAOYSA-N 0.000 description 1
- GNXFOGHNGIVQEH-UHFFFAOYSA-N 2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate Chemical compound COC1=CC=CC=C1OCC(O)COC(N)=O GNXFOGHNGIVQEH-UHFFFAOYSA-N 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- NBKKDJACJZJGAT-ZDUSSCGKSA-N C/C(/[C@@H](c(cccc1)c1Cl)OC)=[O]\C(N=C1CC1)=O Chemical compound C/C(/[C@@H](c(cccc1)c1Cl)OC)=[O]\C(N=C1CC1)=O NBKKDJACJZJGAT-ZDUSSCGKSA-N 0.000 description 1
- KLKWPWZWEXKFTR-UHFFFAOYSA-N CC(C(C1=CC=CC=C1Cl)C2(CCCCC2)OC(=O)N)O Chemical compound CC(C(C1=CC=CC=C1Cl)C2(CCCCC2)OC(=O)N)O KLKWPWZWEXKFTR-UHFFFAOYSA-N 0.000 description 1
- ZGZUSEVRDVGDIQ-UHFFFAOYSA-N CC(C(c(ccc(Cl)c1)c1Cl)OC(N)=O)O Chemical compound CC(C(c(ccc(Cl)c1)c1Cl)OC(N)=O)O ZGZUSEVRDVGDIQ-UHFFFAOYSA-N 0.000 description 1
- BFNFBBUERWPSQT-UHFFFAOYSA-N CC(C(c(cccc1)c1Cl)OC(N)=O)O Chemical compound CC(C(c(cccc1)c1Cl)OC(N)=O)O BFNFBBUERWPSQT-UHFFFAOYSA-N 0.000 description 1
- KUWDMPSZDLJKRK-UHFFFAOYSA-N CC(C(c1cc(I)ccc1)OCOC)OC(N)=O Chemical compound CC(C(c1cc(I)ccc1)OCOC)OC(N)=O KUWDMPSZDLJKRK-UHFFFAOYSA-N 0.000 description 1
- UNXSPOXYUYQOJX-UHFFFAOYSA-N CC(C(c1ccccc1Cl)OC(NC)=O)O Chemical compound CC(C(c1ccccc1Cl)OC(NC)=O)O UNXSPOXYUYQOJX-UHFFFAOYSA-N 0.000 description 1
- LAOSBLSIOFKVIP-UHFFFAOYSA-N CC(C)C(C(c(c(Cl)ccc1)c1Cl)OC(N)O)O Chemical compound CC(C)C(C(c(c(Cl)ccc1)c1Cl)OC(N)O)O LAOSBLSIOFKVIP-UHFFFAOYSA-N 0.000 description 1
- PXZKDQNKFLIZGH-AXMFPCCJSA-N CC(C)CC(C1=CC=CC=C1Cl)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)O Chemical compound CC(C)CC(C1=CC=CC=C1Cl)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)O PXZKDQNKFLIZGH-AXMFPCCJSA-N 0.000 description 1
- DBZUERPCWQXVJA-NXYBWZTOSA-N CC(C)CC(C1=CC=CC=C1I)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)OC Chemical compound CC(C)CC(C1=CC=CC=C1I)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)OC DBZUERPCWQXVJA-NXYBWZTOSA-N 0.000 description 1
- KLBPXWBHHCQECO-XDPAUIEISA-N CC(C)CC(C1=CC=CC=C1I)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)OCOC Chemical compound CC(C)CC(C1=CC=CC=C1I)([C@@]23CCC(C2)C[C@@H]3NC(=O)O)OCOC KLBPXWBHHCQECO-XDPAUIEISA-N 0.000 description 1
- GLPGQHKPLGDPSL-SKDRFNHKSA-N CC(C)NC(O[C@H](C)[C@@H](c(cccc1)c1Cl)O)=O Chemical compound CC(C)NC(O[C@H](C)[C@@H](c(cccc1)c1Cl)O)=O GLPGQHKPLGDPSL-SKDRFNHKSA-N 0.000 description 1
- CSFUKAVUWNQUCH-QWRGUYRKSA-N CC(C)[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)O)OC(N)=O Chemical compound CC(C)[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)O)OC(N)=O CSFUKAVUWNQUCH-QWRGUYRKSA-N 0.000 description 1
- DOSLSMFLSDYZSV-KBPBESRZSA-N CC(C)[C@@H]([C@H](c(cccc1)c1I)O)OC(NC(C)C)=O Chemical compound CC(C)[C@@H]([C@H](c(cccc1)c1I)O)OC(NC(C)C)=O DOSLSMFLSDYZSV-KBPBESRZSA-N 0.000 description 1
- XLTFFJPZKMIJIV-HOTGVXAUSA-N CC(C)[C@@H]([C@H](c(cccc1)c1I)OC)[O](C(NC1CC1)=O)#C Chemical compound CC(C)[C@@H]([C@H](c(cccc1)c1I)OC)[O](C(NC1CC1)=O)#C XLTFFJPZKMIJIV-HOTGVXAUSA-N 0.000 description 1
- FSXJMVSVOFGOPC-LLVKDONJSA-N CC(C)[C@H](/C(/c(cccc1)c1I)=[O]\C)OC(N)=O Chemical compound CC(C)[C@H](/C(/c(cccc1)c1I)=[O]\C)OC(N)=O FSXJMVSVOFGOPC-LLVKDONJSA-N 0.000 description 1
- JUMAEWQXWKGOLY-LLVKDONJSA-N CC(C)[C@H](C(c(cccc1)c1I)=O)OC(N)=O Chemical compound CC(C)[C@H](C(c(cccc1)c1I)=O)OC(N)=O JUMAEWQXWKGOLY-LLVKDONJSA-N 0.000 description 1
- SJHYQTXVIZHDIL-UHFFFAOYSA-N CC(C1)C1(C(c(cccc1)c1Cl)OCOC)OC(N)=O Chemical compound CC(C1)C1(C(c(cccc1)c1Cl)OCOC)OC(N)=O SJHYQTXVIZHDIL-UHFFFAOYSA-N 0.000 description 1
- QMAZKBSAMIHVNX-GAKQDWLJSA-N CC(C[C@@H]1CCCC[C@]1(C2=CC=CC=C2Cl)OC(=O)N)O Chemical compound CC(C[C@@H]1CCCC[C@]1(C2=CC=CC=C2Cl)OC(=O)N)O QMAZKBSAMIHVNX-GAKQDWLJSA-N 0.000 description 1
- SRFVPWFYVONFQD-LRHAYUFXSA-N CC(C[C@H](c1ccccc1I)O)CN(C1CCCCC1)C(O)=O Chemical compound CC(C[C@H](c1ccccc1I)O)CN(C1CCCCC1)C(O)=O SRFVPWFYVONFQD-LRHAYUFXSA-N 0.000 description 1
- QMAZKBSAMIHVNX-ZLXOECBPSA-N CC(C[C@H]1CCCC[C@@]1(C2=CC=CC=C2Cl)OC(=O)N)O Chemical compound CC(C[C@H]1CCCC[C@@]1(C2=CC=CC=C2Cl)OC(=O)N)O QMAZKBSAMIHVNX-ZLXOECBPSA-N 0.000 description 1
- UTBJUVIPXMIVEW-TYICEKJOSA-N CC([C@@H](c(c(Cl)c1)ccc1Cl)OC)OC(N)=O Chemical compound CC([C@@H](c(c(Cl)c1)ccc1Cl)OC)OC(N)=O UTBJUVIPXMIVEW-TYICEKJOSA-N 0.000 description 1
- HUHXKKFQWXOKAO-UHFFFAOYSA-N CCC(C(c(ccc(Cl)c1)c1Cl)OC(N)O)O Chemical compound CCC(C(c(ccc(Cl)c1)c1Cl)OC(N)O)O HUHXKKFQWXOKAO-UHFFFAOYSA-N 0.000 description 1
- RFAYOCWNHRYRHP-UHFFFAOYSA-N CCC(C(c1cc(I)ccc1)O)O Chemical compound CCC(C(c1cc(I)ccc1)O)O RFAYOCWNHRYRHP-UHFFFAOYSA-N 0.000 description 1
- JTLXRFKYQSDEHJ-VHQFURPBSA-N CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OC Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OC JTLXRFKYQSDEHJ-VHQFURPBSA-N 0.000 description 1
- RLRTXBYDVJUMHJ-VHQFURPBSA-N CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC RLRTXBYDVJUMHJ-VHQFURPBSA-N 0.000 description 1
- RDRWLJRBKFQKIH-ZWBSKUQPSA-N CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2Cl)OC Chemical compound CCC([C@]1(CCCC[C@@H]1OC(=O)N)C2=CC=CC=C2Cl)OC RDRWLJRBKFQKIH-ZWBSKUQPSA-N 0.000 description 1
- UKLYRZNKLPACSL-VHQFURPBSA-N CCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O Chemical compound CCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O UKLYRZNKLPACSL-VHQFURPBSA-N 0.000 description 1
- AYPBZSBRJSSKFQ-LQVSYIOISA-N CCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC Chemical compound CCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC AYPBZSBRJSSKFQ-LQVSYIOISA-N 0.000 description 1
- NSCCNHQBVLPFMF-VEAWUBTESA-N CCCCC(CC)NC(O[C@H](C)C(c(cccc1)c1Cl)O)=O Chemical compound CCCCC(CC)NC(O[C@H](C)C(c(cccc1)c1Cl)O)=O NSCCNHQBVLPFMF-VEAWUBTESA-N 0.000 description 1
- ONJHRWBRFOEGKM-ARLHGKGLSA-N CCCCC([C@@H](c1cc(I)ccc1)OCOC)OC(N)=O Chemical compound CCCCC([C@@H](c1cc(I)ccc1)OCOC)OC(N)=O ONJHRWBRFOEGKM-ARLHGKGLSA-N 0.000 description 1
- QLJUWCFJAYVSEJ-URHMHZEASA-N CCCCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O Chemical compound CCCCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O QLJUWCFJAYVSEJ-URHMHZEASA-N 0.000 description 1
- UHHYVMDXCIOGAW-YSKQTFSLSA-N CCCCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC Chemical compound CCCCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OC UHHYVMDXCIOGAW-YSKQTFSLSA-N 0.000 description 1
- AHMHRSDRCGVUMR-QXQDIAAESA-N CCCC[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)OC(N)O)OC(N)=O Chemical compound CCCC[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)OC(N)O)OC(N)=O AHMHRSDRCGVUMR-QXQDIAAESA-N 0.000 description 1
- JIPJAFZYOGZPJK-KBPBESRZSA-N CCCC[C@@H]([C@H](c(cc1)ccc1F)OCOC)OC(N)=O Chemical compound CCCC[C@@H]([C@H](c(cc1)ccc1F)OCOC)OC(N)=O JIPJAFZYOGZPJK-KBPBESRZSA-N 0.000 description 1
- HFFZZCRFHKJXKI-RYUDHWBXSA-N CCCC[C@@H]([C@H](c(cccc1)c1I)OC(N)=O)OC(N)=O Chemical compound CCCC[C@@H]([C@H](c(cccc1)c1I)OC(N)=O)OC(N)=O HFFZZCRFHKJXKI-RYUDHWBXSA-N 0.000 description 1
- SZHHRLQMLGYAMG-PMACEKPBSA-N CCCC[C@@H]([C@H](c1c(C)cccc1)O)OC(NCc1ccccc1)=O Chemical compound CCCC[C@@H]([C@H](c1c(C)cccc1)O)OC(NCc1ccccc1)=O SZHHRLQMLGYAMG-PMACEKPBSA-N 0.000 description 1
- VUHYSWDWZMNPTR-CHWSQXEVSA-N CCCC[C@H]([C@@H](c(cc1)ccc1F)OC)OC(N)=O Chemical compound CCCC[C@H]([C@@H](c(cc1)ccc1F)OC)OC(N)=O VUHYSWDWZMNPTR-CHWSQXEVSA-N 0.000 description 1
- OPCVYXWEYIXFJO-JOYOIKCWSA-N CCCNC(O[C@@H](C)[C@H](c(cccc1)c1F)O)=O Chemical compound CCCNC(O[C@@H](C)[C@H](c(cccc1)c1F)O)=O OPCVYXWEYIXFJO-JOYOIKCWSA-N 0.000 description 1
- DGSFLFPXNLOZIL-SZSXPDSJSA-N CCCOC([C@@H](C)OC(N)=O)c(cccc1Cl)c1Cl Chemical compound CCCOC([C@@H](C)OC(N)=O)c(cccc1Cl)c1Cl DGSFLFPXNLOZIL-SZSXPDSJSA-N 0.000 description 1
- HLIGNGNIWIZIKB-WCBMZHEXSA-N CC[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)OC(N)=O)OC(N)=O Chemical compound CC[C@@H]([C@H](c(c(Cl)ccc1)c1Cl)OC(N)=O)OC(N)=O HLIGNGNIWIZIKB-WCBMZHEXSA-N 0.000 description 1
- CIZYCYKWJIXLJV-KBPBESRZSA-N CC[C@@H]([C@H](c(cccc1)c1I)OC)OC(NC(C)C)=O Chemical compound CC[C@@H]([C@H](c(cccc1)c1I)OC)OC(NC(C)C)=O CIZYCYKWJIXLJV-KBPBESRZSA-N 0.000 description 1
- QYZJAOLHNLWECC-RYUDHWBXSA-N CC[C@@H]([C@H](c1cc(I)ccc1)OCOC)OC(N)=O Chemical compound CC[C@@H]([C@H](c1cc(I)ccc1)OCOC)OC(N)=O QYZJAOLHNLWECC-RYUDHWBXSA-N 0.000 description 1
- NYVIWJIKYGRTKS-KOLCDFICSA-N CC[C@H]([C@@H](c(c(Cl)ccc1)c1Cl)OC)OC(N)=O Chemical compound CC[C@H]([C@@H](c(c(Cl)ccc1)c1Cl)OC)OC(N)=O NYVIWJIKYGRTKS-KOLCDFICSA-N 0.000 description 1
- QKKMXCWAANBEDO-SECBINFHSA-N CN(C([C@@H](c(cccc1)c1Cl)O)=O)OC Chemical compound CN(C([C@@H](c(cccc1)c1Cl)O)=O)OC QKKMXCWAANBEDO-SECBINFHSA-N 0.000 description 1
- PYYVGPHJPVYHHX-UHFFFAOYSA-N COCC[AlH]CCOC.[Na] Chemical compound COCC[AlH]CCOC.[Na] PYYVGPHJPVYHHX-UHFFFAOYSA-N 0.000 description 1
- JALVFPYVPTWYTL-IMTBSYHQSA-N C[C@@H]([C@H](c(cc1)ccc1F)O)OC(N)=O Chemical compound C[C@@H]([C@H](c(cc1)ccc1F)O)OC(N)=O JALVFPYVPTWYTL-IMTBSYHQSA-N 0.000 description 1
- XMZRLLHJWDEVKV-GZMMTYOYSA-N C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(N)=O Chemical compound C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(N)=O XMZRLLHJWDEVKV-GZMMTYOYSA-N 0.000 description 1
- MJJJBKLPBYJUPY-JJPSJUEGSA-N C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(NC1C(CC2)CC2C1)=O Chemical compound C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(NC1C(CC2)CC2C1)=O MJJJBKLPBYJUPY-JJPSJUEGSA-N 0.000 description 1
- WWGISPBKNQWDTK-IINYFYTJSA-N C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(NC1CC1)=O Chemical compound C[C@@H]([C@H](c(cccc1)c1Cl)OCOC)OC(NC1CC1)=O WWGISPBKNQWDTK-IINYFYTJSA-N 0.000 description 1
- FRTKCHUZSCPVLV-QPUJVOFHSA-N C[C@@H]([C@H](c(cccc1)c1F)O)OC(NC1CC1)=O Chemical compound C[C@@H]([C@H](c(cccc1)c1F)O)OC(NC1CC1)=O FRTKCHUZSCPVLV-QPUJVOFHSA-N 0.000 description 1
- BJIVJMMNJDBRKM-KBXCAEBGSA-N C[C@@H]([C@H](c(cccc1)c1I)OCOC)OC(NCc1ccccc1)=O Chemical compound C[C@@H]([C@H](c(cccc1)c1I)OCOC)OC(NCc1ccccc1)=O BJIVJMMNJDBRKM-KBXCAEBGSA-N 0.000 description 1
- HCQQTRHMOFUCFS-WCBMZHEXSA-N C[C@@H]([C@H](c1c(C)cccc1)O)OC(N)=O Chemical compound C[C@@H]([C@H](c1c(C)cccc1)O)OC(N)=O HCQQTRHMOFUCFS-WCBMZHEXSA-N 0.000 description 1
- YONFXFKZGZUDCL-GXSJLCMTSA-N C[C@@H]([C@H](c1c(C)cccc1)O)OC(NC)=O Chemical compound C[C@@H]([C@H](c1c(C)cccc1)O)OC(NC)=O YONFXFKZGZUDCL-GXSJLCMTSA-N 0.000 description 1
- FBVCCOOCTKJPGI-DYVFJYSZSA-N C[C@H]([C@@H](c(cccc1)c1Cl)OCOC)OC(NC1CCCCC1)=O Chemical compound C[C@H]([C@@H](c(cccc1)c1Cl)OCOC)OC(NC1CCCCC1)=O FBVCCOOCTKJPGI-DYVFJYSZSA-N 0.000 description 1
- FRGSWDBQPNDMKU-KCJUWKMLSA-N C[C@H]([C@@H](c(cccc1)c1F)OCOC)OC(N)=O Chemical compound C[C@H]([C@@H](c(cccc1)c1F)OCOC)OC(N)=O FRGSWDBQPNDMKU-KCJUWKMLSA-N 0.000 description 1
- UJWFRIDRWQXXTF-ANLVUFKYSA-N C[C@H]([C@@H](c(cccc1Cl)c1Cl)O)OC(N)=O Chemical compound C[C@H]([C@@H](c(cccc1Cl)c1Cl)O)OC(N)=O UJWFRIDRWQXXTF-ANLVUFKYSA-N 0.000 description 1
- LQNPALRHZKVYRZ-PELKAZGASA-N C[C@H]([C@@H](c1ccccc1N)OC)OC(C)=O Chemical compound C[C@H]([C@@H](c1ccccc1N)OC)OC(C)=O LQNPALRHZKVYRZ-PELKAZGASA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- JAZBJYUPWRATFC-UHFFFAOYSA-N ClC1=C(C=O)C(=CC=C1)Cl.ClC1=C(C=O)C(=CC=C1)Cl Chemical compound ClC1=C(C=O)C(=CC=C1)Cl.ClC1=C(C=O)C(=CC=C1)Cl JAZBJYUPWRATFC-UHFFFAOYSA-N 0.000 description 1
- FPVVJIAMWVZJGC-HFEGYEGKSA-N ClC1=C([C@H](C(=O)O)O)C=CC=C1.ClC1=C([C@H](C(=O)O)O)C=CC=C1 Chemical compound ClC1=C([C@H](C(=O)O)O)C=CC=C1.ClC1=C([C@H](C(=O)O)O)C=CC=C1 FPVVJIAMWVZJGC-HFEGYEGKSA-N 0.000 description 1
- HGIRFJNGXGAKPC-UHFFFAOYSA-N ClC=1C=CC=C(C=O)C1Cl.ClC=1C=CC=C(C=O)C1Cl Chemical compound ClC=1C=CC=C(C=O)C1Cl.ClC=1C=CC=C(C=O)C1Cl HGIRFJNGXGAKPC-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000034819 Mobility Limitation Diseases 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- GRJFOHXUXQUSOG-MRVPVSSYSA-N OC[C@H](c(cccc1)c1F)O Chemical compound OC[C@H](c(cccc1)c1F)O GRJFOHXUXQUSOG-MRVPVSSYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000219781 Pueraria montana var. lobata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- VUOQIVBOQRZUIN-BXKDBHETSA-N [(1R)-1-(2-chlorophenyl)propyl]-[(2R)-2-hydroxypropyl]carbamic acid Chemical compound C[C@@H](O)CN(C(O)=O)[C@H](CC)C1=CC=CC=C1Cl VUOQIVBOQRZUIN-BXKDBHETSA-N 0.000 description 1
- YNCOOSAZFXQCOG-QVTLUWRMSA-N [(1R,2R)-1-(2-chlorophenyl)-2-(1-hydroxypropyl)-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@]1(CC2CC[C@@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)O YNCOOSAZFXQCOG-QVTLUWRMSA-N 0.000 description 1
- QWRFCWBYMPDONM-QRYBPTEFSA-N [(1R,2R)-2-(2-chlorophenyl)cyclohexyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(N([C@@H]1CCCC[C@@H]1C2=CC=CC=C2Cl)C(=O)O)O QWRFCWBYMPDONM-QRYBPTEFSA-N 0.000 description 1
- VIFLGWSKHXUSBN-DFWSTUSTSA-N [(1R,2R)-2-(2-chlorophenyl)cyclopropyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(O)N(C(O)=O)[C@@H]1C[C@@H]1C1=CC=CC=C1Cl VIFLGWSKHXUSBN-DFWSTUSTSA-N 0.000 description 1
- VUOQIVBOQRZUIN-CABZTGNLSA-N [(1S)-1-(2-chlorophenyl)propyl]-[(2S)-2-hydroxypropyl]carbamic acid Chemical compound C[C@H](O)CN(C(O)=O)[C@@H](CC)C1=CC=CC=C1Cl VUOQIVBOQRZUIN-CABZTGNLSA-N 0.000 description 1
- XMWLQHSCMJSNEW-CABZTGNLSA-N [(1S)-1-carbamoyloxypropyl]-[(2S)-1-(2-chlorophenyl)propan-2-yl]carbamic acid Chemical compound NC(=O)O[C@@H](CC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1Cl XMWLQHSCMJSNEW-CABZTGNLSA-N 0.000 description 1
- IGYNAGJIAMDCIO-GWCFXTLKSA-N [(1S)-1-hydroxybutyl]-[(2S)-1-(2-iodophenyl)propan-2-yl]carbamic acid Chemical compound CCC[C@H](O)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I IGYNAGJIAMDCIO-GWCFXTLKSA-N 0.000 description 1
- DPUCEUCLNQKIJO-WFASDCNBSA-N [(1S)-1-hydroxyhexyl]-[(2S)-1-(2-iodophenyl)propan-2-yl]carbamic acid Chemical compound CCCCC[C@H](O)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I DPUCEUCLNQKIJO-WFASDCNBSA-N 0.000 description 1
- DWJFXIJYXVWYIJ-CABZTGNLSA-N [(1S)-1-hydroxypropyl]-[(2S)-1-(2-iodophenyl)propan-2-yl]carbamic acid Chemical compound CC[C@H](O)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I DWJFXIJYXVWYIJ-CABZTGNLSA-N 0.000 description 1
- QWRFCWBYMPDONM-JEIKQXNFSA-N [(1S,2R)-2-(2-chlorophenyl)cyclohexyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(N([C@H]1CCCC[C@@H]1C2=CC=CC=C2Cl)C(=O)O)O QWRFCWBYMPDONM-JEIKQXNFSA-N 0.000 description 1
- VIFLGWSKHXUSBN-BVAQLPTGSA-N [(1S,2R)-2-(2-chlorophenyl)cyclopropyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(O)N(C(O)=O)[C@H]1C[C@@H]1C1=CC=CC=C1Cl VIFLGWSKHXUSBN-BVAQLPTGSA-N 0.000 description 1
- PRWNGPAGJVGFAJ-LQVSYIOISA-N [(1S,2S)-1-(2-chlorophenyl)-2-[1-(methoxymethoxy)propyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3Cl)NC(=O)O)OCOC PRWNGPAGJVGFAJ-LQVSYIOISA-N 0.000 description 1
- RTEFOWFQPNWORG-DMJNXXHZSA-N [(1S,2S)-1-(2-fluorophenyl)-2-(1-hydroxypropyl)-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3F)NC(=O)O)O RTEFOWFQPNWORG-DMJNXXHZSA-N 0.000 description 1
- YFGARXJJDSVMPY-VHQFURPBSA-N [(1S,2S)-1-(2-fluorophenyl)-2-(1-methoxypropyl)-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3F)NC(=O)O)OC YFGARXJJDSVMPY-VHQFURPBSA-N 0.000 description 1
- BISGHHTWSKSWHW-LQVSYIOISA-N [(1S,2S)-1-(2-fluorophenyl)-2-[1-(methoxymethoxy)propyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3F)NC(=O)O)OCOC BISGHHTWSKSWHW-LQVSYIOISA-N 0.000 description 1
- AIXOTPWMJWYRBL-URHMHZEASA-N [(1S,2S)-1-(2-iodophenyl)-2-[1-(methoxymethoxy)butyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OCOC AIXOTPWMJWYRBL-URHMHZEASA-N 0.000 description 1
- WFQZIEYPQQODAD-QGUJQFKUSA-N [(1S,2S)-1-(2-iodophenyl)-2-[1-(methoxymethoxy)hexyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCCCCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OCOC WFQZIEYPQQODAD-QGUJQFKUSA-N 0.000 description 1
- IXHPACNSUMDYLZ-LQVSYIOISA-N [(1S,2S)-1-(2-iodophenyl)-2-[1-(methoxymethoxy)propyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC([C@@]1(CC2CC[C@]1(C2)C3=CC=CC=C3I)NC(=O)O)OCOC IXHPACNSUMDYLZ-LQVSYIOISA-N 0.000 description 1
- LNGFFOVVYWDHCT-JFXOEICMSA-N [(1S,2S)-2-(2-chlorophenyl)cyclohexyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@H]1CCCC[C@H]1C1=CC=CC=C1Cl LNGFFOVVYWDHCT-JFXOEICMSA-N 0.000 description 1
- STWAEMYMXIXAHP-QDYONFDCSA-N [(1S,2S)-2-(2-chlorophenyl)cyclopropyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1Cl STWAEMYMXIXAHP-QDYONFDCSA-N 0.000 description 1
- CUUDTYKUXFZHOX-ULVQEXTCSA-N [(1S,2S)-2-(2-chlorophenyl)cyclopropyl]-[1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCOC(CC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1Cl CUUDTYKUXFZHOX-ULVQEXTCSA-N 0.000 description 1
- SBGSWWXQGXVVSR-XRJCJLGXSA-N [(1S,2S)-2-(2-fluorophenyl)cyclohexyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(N([C@H]1CCCC[C@H]1C2=CC=CC=C2F)C(=O)O)O SBGSWWXQGXVVSR-XRJCJLGXSA-N 0.000 description 1
- SONUKJKCDHGWOR-JFXOEICMSA-N [(1S,2S)-2-(2-fluorophenyl)cyclohexyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@H]1CCCC[C@H]1C1=CC=CC=C1F SONUKJKCDHGWOR-JFXOEICMSA-N 0.000 description 1
- QYILGJLMTNPSGV-HFLPBZFISA-N [(1S,2S)-2-(2-fluorophenyl)cyclopropyl]-(1-hydroxypropyl)carbamic acid Chemical compound CCC(O)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1F QYILGJLMTNPSGV-HFLPBZFISA-N 0.000 description 1
- KYBANCDXLZYZNG-QDYONFDCSA-N [(1S,2S)-2-(2-fluorophenyl)cyclopropyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1F KYBANCDXLZYZNG-QDYONFDCSA-N 0.000 description 1
- MKLLAWOMEXQAPZ-ULVQEXTCSA-N [(1S,2S)-2-(2-fluorophenyl)cyclopropyl]-[1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCOC(CC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1F MKLLAWOMEXQAPZ-ULVQEXTCSA-N 0.000 description 1
- SXELCAPUHUZPSU-ULVQEXTCSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-(1-methoxybutyl)carbamic acid Chemical compound CCCC(OC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I SXELCAPUHUZPSU-ULVQEXTCSA-N 0.000 description 1
- UVIIAUZXBNLMTR-JFXOEICMSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-(1-methoxyhexyl)carbamic acid Chemical compound CCCCCC(OC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I UVIIAUZXBNLMTR-JFXOEICMSA-N 0.000 description 1
- RRAZAGJDPKPHLG-QDYONFDCSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-(1-methoxypropyl)carbamic acid Chemical compound CCC(OC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I RRAZAGJDPKPHLG-QDYONFDCSA-N 0.000 description 1
- APRXVTQUJKDAFF-XRJCJLGXSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-[1-(methoxymethoxy)butyl]carbamic acid Chemical compound COCOC(CCC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I APRXVTQUJKDAFF-XRJCJLGXSA-N 0.000 description 1
- WTFSCEKHWPDFOV-CCWDIYBNSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-[1-(methoxymethoxy)hexyl]carbamic acid Chemical compound CCCCCC(OCOC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I WTFSCEKHWPDFOV-CCWDIYBNSA-N 0.000 description 1
- WMQWSPDIEGQEGA-ULVQEXTCSA-N [(1S,2S)-2-(2-iodophenyl)cyclopropyl]-[1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCOC(CC)N(C(O)=O)[C@H]1C[C@H]1C1=CC=CC=C1I WMQWSPDIEGQEGA-ULVQEXTCSA-N 0.000 description 1
- RQLVGAOLNBAXSX-SJQFFEKCSA-N [(1s,2s)-2-(1-hydroxyhexyl)-2-(2-iodophenyl)cyclohexyl] carbamate Chemical compound C=1C=CC=C(I)C=1[C@]1(C(O)CCCCC)CCCC[C@@H]1OC(N)=O RQLVGAOLNBAXSX-SJQFFEKCSA-N 0.000 description 1
- NIONSJAMPOVFMA-DSUHRAPHSA-N [(1s,2s)-2-(1-hydroxypropyl)-2-(2-iodophenyl)cyclohexyl] carbamate Chemical compound C=1C=CC=C(I)C=1[C@]1(C(O)CC)CCCC[C@@H]1OC(N)=O NIONSJAMPOVFMA-DSUHRAPHSA-N 0.000 description 1
- YGWCUTYEKUPJLT-CCLCZBONSA-N [(1s,2s)-2-[1-hydroxy-1-(2-iodophenyl)-3-methylbutyl]cyclohexyl] carbamate Chemical compound C=1C=CC=C(I)C=1C(O)(CC(C)C)[C@H]1CCCC[C@@H]1OC(N)=O YGWCUTYEKUPJLT-CCLCZBONSA-N 0.000 description 1
- KMJIXHAQUAHFET-BXKDBHETSA-N [(2R)-1-(2-chlorophenyl)propan-2-yl]-[(1R)-1-hydroxypropyl]carbamic acid Chemical compound CC[C@@H](O)N(C(O)=O)[C@H](C)CC1=CC=CC=C1Cl KMJIXHAQUAHFET-BXKDBHETSA-N 0.000 description 1
- HVFPQONMEHRNGY-FZMZJTMJSA-N [(2S)-1-(2-chlorophenyl)propan-2-yl]-[(1S)-1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCO[C@@H](CC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1Cl HVFPQONMEHRNGY-FZMZJTMJSA-N 0.000 description 1
- KMJIXHAQUAHFET-CABZTGNLSA-N [(2S)-1-(2-chlorophenyl)propan-2-yl]-[(1S)-1-hydroxypropyl]carbamic acid Chemical compound CC[C@H](O)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1Cl KMJIXHAQUAHFET-CABZTGNLSA-N 0.000 description 1
- ZDLPJFDFZWWSGI-GWCFXTLKSA-N [(2S)-1-(2-chlorophenyl)propan-2-yl]-[(1S)-1-methoxypropyl]carbamic acid Chemical compound CC[C@H](OC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1Cl ZDLPJFDFZWWSGI-GWCFXTLKSA-N 0.000 description 1
- BEGCMCTXHXABHJ-FZMZJTMJSA-N [(2S)-1-(2-fluorophenyl)propan-2-yl]-[(1S)-1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCO[C@@H](CC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1F BEGCMCTXHXABHJ-FZMZJTMJSA-N 0.000 description 1
- LKCCEJMUFKDFEP-CABZTGNLSA-N [(2S)-1-(2-fluorophenyl)propan-2-yl]-[(1S)-1-hydroxypropyl]carbamic acid Chemical compound CC[C@H](O)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1F LKCCEJMUFKDFEP-CABZTGNLSA-N 0.000 description 1
- URLWBKNNJMLBBO-GWCFXTLKSA-N [(2S)-1-(2-fluorophenyl)propan-2-yl]-[(1S)-1-methoxypropyl]carbamic acid Chemical compound CC[C@H](OC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1F URLWBKNNJMLBBO-GWCFXTLKSA-N 0.000 description 1
- SLUZZJJCUTULAQ-WFASDCNBSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-(methoxymethoxy)butyl]carbamic acid Chemical compound COCO[C@@H](CCC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I SLUZZJJCUTULAQ-WFASDCNBSA-N 0.000 description 1
- BMTWYOCSXBFUBY-YOEHRIQHSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-(methoxymethoxy)hexyl]carbamic acid Chemical compound CCCCC[C@H](OCOC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I BMTWYOCSXBFUBY-YOEHRIQHSA-N 0.000 description 1
- WXOYJLHXZIHERP-FZMZJTMJSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-(methoxymethoxy)propyl]carbamic acid Chemical compound COCO[C@@H](CC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I WXOYJLHXZIHERP-FZMZJTMJSA-N 0.000 description 1
- FAPFEDKFIDYBLY-FZMZJTMJSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-methoxybutyl]carbamic acid Chemical compound CCC[C@H](OC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I FAPFEDKFIDYBLY-FZMZJTMJSA-N 0.000 description 1
- MMKZJMXTAPPEPG-BBRMVZONSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-methoxyhexyl]carbamic acid Chemical compound CCCCC[C@H](OC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I MMKZJMXTAPPEPG-BBRMVZONSA-N 0.000 description 1
- BXLPYNJEWHOMDI-GWCFXTLKSA-N [(2S)-1-(2-iodophenyl)propan-2-yl]-[(1S)-1-methoxypropyl]carbamic acid Chemical compound CC[C@H](OC)N(C(O)=O)[C@@H](C)CC1=CC=CC=C1I BXLPYNJEWHOMDI-GWCFXTLKSA-N 0.000 description 1
- WPEULGYHJPVUHX-UHFFFAOYSA-N [1-(2-chlorophenyl)-1-hydroxypropyl]-cyclohexylcarbamic acid Chemical compound C=1C=CC=C(Cl)C=1C(O)(CC)N(C(O)=O)C1CCCCC1 WPEULGYHJPVUHX-UHFFFAOYSA-N 0.000 description 1
- ZNAWPYNOBWIEDS-UHFFFAOYSA-N [1-(2-chlorophenyl)-1-hydroxypropyl]-cyclopropylcarbamic acid Chemical compound C=1C=CC=C(Cl)C=1C(O)(CC)N(C(O)=O)C1CC1 ZNAWPYNOBWIEDS-UHFFFAOYSA-N 0.000 description 1
- CPZJJVVWUYEESA-UHFFFAOYSA-N [1-(2-chlorophenyl)-1-hydroxypropyl]-propan-2-ylcarbamic acid Chemical compound CC(C)N(C(O)=O)C(O)(CC)C1=CC=CC=C1Cl CPZJJVVWUYEESA-UHFFFAOYSA-N 0.000 description 1
- UGAKEXNCSVTKPP-UHFFFAOYSA-N [1-(2-chlorophenyl)-2-hydroxypropyl]-cyclopropylcarbamic acid Chemical compound C=1C=CC=C(Cl)C=1C(C(O)C)N(C(O)=O)C1CC1 UGAKEXNCSVTKPP-UHFFFAOYSA-N 0.000 description 1
- YZOGTHTZGZQIPP-UHFFFAOYSA-N [1-(2-chlorophenyl)-2-hydroxypropyl]-propan-2-ylcarbamic acid Chemical compound CC(C)N(C(O)=O)C(C(C)O)C1=CC=CC=C1Cl YZOGTHTZGZQIPP-UHFFFAOYSA-N 0.000 description 1
- LUAQZNAIHQMVEH-UHFFFAOYSA-N [1-(2-chlorophenyl)-2-hydroxypropyl]-propylcarbamic acid Chemical compound CCCN(C(O)=O)C(C(C)O)C1=CC=CC=C1Cl LUAQZNAIHQMVEH-UHFFFAOYSA-N 0.000 description 1
- MSRXYKLIYDFBSJ-UHFFFAOYSA-N [1-[1-(2-chlorophenyl)-1-hydroxypropyl]-2-bicyclo[2.2.1]heptanyl]carbamic acid Chemical compound CCC(C1=CC=CC=C1Cl)(C23CCC(C2)CC3NC(=O)O)O MSRXYKLIYDFBSJ-UHFFFAOYSA-N 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- XXFXTBNFFMQVKJ-UHFFFAOYSA-N [diphenyl(trityloxy)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XXFXTBNFFMQVKJ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000009227 behaviour therapy Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 description 1
- JKJWYKGYGWOAHT-UHFFFAOYSA-N bis(prop-2-enyl) carbonate Chemical compound C=CCOC(=O)OCC=C JKJWYKGYGWOAHT-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- GZSSFSARCMSPPW-UHFFFAOYSA-N butane-2,2-diol Chemical compound CCC(C)(O)O GZSSFSARCMSPPW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- OFZCIYFFPZCNJE-UHFFFAOYSA-N carisoprodol Chemical compound NC(=O)OCC(C)(CCC)COC(=O)NC(C)C OFZCIYFFPZCNJE-UHFFFAOYSA-N 0.000 description 1
- 229960004587 carisoprodol Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WEQAYVWKMWHEJO-UHFFFAOYSA-N chlormezanone Chemical compound O=S1(=O)CCC(=O)N(C)C1C1=CC=C(Cl)C=C1 WEQAYVWKMWHEJO-UHFFFAOYSA-N 0.000 description 1
- 229960002810 chlormezanone Drugs 0.000 description 1
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229960002565 eperisone Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000001153 interneuron Anatomy 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229960002330 methocarbamol Drugs 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000096 monohydride Inorganic materials 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- TYZYRCHEVXXLSJ-UHFFFAOYSA-N phenylmethoxymethoxymethoxymethylbenzene Chemical compound C=1C=CC=CC=1COCOCOCC1=CC=CC=C1 TYZYRCHEVXXLSJ-UHFFFAOYSA-N 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000010825 rotarod performance test Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037152 sensory function Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000013363 skeletal muscle disease Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001476 sodium potassium tartrate Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 1
- 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/02—Carbamic acids; Salts of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
[化学式1]
Xは、ハロゲン、例えば、塩素、フッ素、ヨウ素、または臭素基であり、
nは、1〜5の整数、例えば、1または2であり、
R1は、水素またはC1〜C4の直鎖もしくは分枝鎖アルキル基、例えば、メチル基、エチル基、イソプロピル基、またはブチル基であり、
Aは、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基(例えば、メチル基など)、C2〜C4のアルコキシアルキルエーテル基(例えば、メトキシメチル基(MOM)など)、および化学式
Bは、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基(例えば、メチル基など)、C2〜C4のアルコキシアルキルエーテル基(例えば、メトキシメチル基(MOM)など)、および化学式
R2およびR3は、互いに同一または異なっていてもよく、それぞれ独立に、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基、例えば、C1〜C3、C3〜C8のシクロアルキル基、例えば、C3−C7、およびベンジル基からなる群より選択されたものであってよく、より詳細には、R2およびR3は、互いに同一または異なっていてもよく、それぞれ独立に、水素、メチル基、プロピル基、イソプロピル基、シクロプロピル基、シクロヘキシル基、ビシクロヘプタン基、およびベンジル基からなる群より選択されたものであってもよい。
Xは、ハロゲン、例えば、塩素、フッ素、ヨウ素、または臭素基であり、
nは、1〜5の整数、例えば、1または2であり、
R1は、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基、例えば、メチル基、エチル基、イソプロピル基、またはブチル基であり、
Aは、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基(例えば、メチル基など)、C2〜C4のアルコキシアルキルエーテル基(例えば、メトキシメチル基(MOM)など)、および
Bは、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基(例えば、メチル基など)、C2〜C4のアルコキシアルキルエーテル基(例えば、メトキシメチル基(MOM)など)、および
R2およびR3は、互いに同一または異なっていてもよく、それぞれ独立に、水素、C1〜C4の直鎖もしくは分枝鎖アルキル基、例えば、C1〜C3、C3〜C8のシクロアルキル基、例えば、C3−C7、およびベンジル基からなる群より選択されたものであり、例えば、R2およびR3は、互いに同一または異なっていてもよく、それぞれ独立に、水素、メチル基、プロピル基、イソプロピル基、シクロプロピル基、シクロヘキシル基、ビシクロヘプタン基、およびベンジル基からなる群より選択されたものであってよい。
1−(2−クロロフェニル)−2−カルバモイルオキシプロピル−N−メチルカルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシプロピル−1−N−プロピルカルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−エチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−エチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−エチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2,3−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−エチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−エチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−エチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,3−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,5−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,6−ジフルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−2−(メトキシメトキシ)−プロピル−1−カルバメート、
1−(2−クロロフェニル)−2−(メトキシ)−プロピル−1−カルバメート、および
化合物のラセミ体、化合物の鏡像異性体、化合物の部分立体異性体、化合物の鏡像異性体の混合物、または化合物の部分立体異性体の混合物。
反応式I:ジオール−1の製造
1H NMR(400MHz, CDCl3) δ1.94(d, J=4.8Hz, 3H), 6.24(m, 1H), 6.78(d, J=14Hz, 1H), 7.11〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=7.6Hz, 3H), 2.29〜2.33(m, 2H), 6.28(dt, J=16Hz, 6.4Hz, 1H), 6.78(d, J=15.6Hz, 1H), 7.13〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=6.8Hz, 6H), 2.25〜2.57(m, 1H), 6.20(dd, J=16Hz, 7.2Hz, 1H), 7.64(d, J=16Hz, 1H), 7.12〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.33〜1.56(m, 4H), 2.26〜2.32(m, 4H), 6.24(dt, J=15.6Hz, 7Hz, 1H), 6.78(d, J=16Hz, 1H), 7.13〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.95(dd, J=6.8Hz, 1.6Hz, 3H), 6.24(m, 1H), 6.72(d, J=15.6Hz, 1H), 7.18〜7.44(m, 3H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=7.6Hz, 3H), 2.20〜2.33(m, 2H), 6.26(dt, J=16Hz, 6.8Hz, 1H), 6.70(d, J=15.6Hz, 1H), 7.18〜7.46(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.8Hz, 6H), 2.53〜2.58(m, 1H), 6.19(dd, J=16.4Hz, 6.8Hz, 1H), 6.31(d, J=16.4Hz, 1H), 7.18〜7.46(m, 3H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.38〜1.52(m, 4H), 2.25〜2.31(m, 2H), 6.22(dt, J=15.6Hz, 6.8Hz, 1H), 6.70(d, J=15.6Hz, 1H), 7.18〜7.46(m, 3H)
1H NMR(400MHz, CDCl3) δ1.98(d, J=8Hz, 3H), 6.23〜6.31(m, 1H), 6.40(d, J=16Hz, 1H), 7.05〜7.32(m, 3H)
1H NMR(400MHz, CDCl3) δ1.17(t, J=7.6Hz, 3H), 2.30〜2.37(m, 2H), 6.29(dt, J=16.4Hz, 6Hz, 1H), 6.37(d, J=16.4Hz, 1H), 7.05〜7.32(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.8Hz, 6H), 2.53〜2.58(m, 1H), 6.19(dd, J=16.4Hz, 6.8Hz, 1H), 6.31(d, J=16.4Hz, 1H), 7.05〜7.32(m, 3H)
1H NMR(400MHz, CDCl3) δ0.99(t, J=7.2Hz, 3H),1.14〜1.59(m, 4H), 2.30〜2.36(m, 2H), 6.24(dt, J=16Hz, 6.6Hz, 1H), 6.38(d, J=16.4Hz, 1H), 7.05〜7.33(m, 3H)
1H NMR(400MHz, CDCl3) δ1.94(d, J=4.8Hz, 3H), 6.24(m, 1H), 6.78(d, J=14Hz, 1H), 7.11〜7.51(m, 3H)
1H NMR(400MHz, CDCl3) δ1.20(d, J=6.4Hz, 3H), 2.48(d, J=4.0Hz 1H), 2.92(d, J=4.4Hz, 1H), 3.93〜3.97(m, 1H), 4.97(t, J=4.8Hz, 1H), 7.22〜7.51(m, 4H)
13CNMR(100MHz,CDCl3) δ18.8, 71.5, 74.4, 127.1, 128.1, 128.9, 129.5, 132.6, 138.9
1H NMR(400MHz, CDCl3) δ1.20(d, J=6.4Hz, 3H), 2.48(d, J=4.0Hz, 1H), 2.92(d, J=4.4Hz, 1H), 3.93〜3.97(m, 1H), 4.97(t, J=4.8Hz, 1H), 7.22〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ1.20(d, J=6.4Hz, 3H), 2.48(d, J=4.0Hz, 1H), 2.92(d, J=4.4Hz, 1H), 3.93〜3.97(m, 1H), 4.97(t, J=4.8Hz, 1H), 7.22〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(t, J=7.4Hz, 3H), 1.52〜1.65(m, 2H), 2.01(d, J=4.4Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.69〜3.75(m, 1H), 5.05(t, J=5.0Hz, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(t, J=7.4Hz, 3H), 1.52〜1.65(m, 2H), 2.01(d, J=4.4Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.69〜3.75(m, 1H), 5.05(t, J=5.0Hz, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(t, J=7.4Hz, 3H), 1.52〜1.65(m, 2H), 2.01(d, J=4.4Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.69〜3.75(m, 1H), 5.05(t, J=5.0Hz, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 7.23〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.82〜1.90(m, 1H), 1.93(d, J=5.6Hz, 1H), 2.79(d, J=6Hz, 1H), 3.53〜3.57(m, 1H), 5.23〜5.25(m, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.90(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 7.23〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 7.23〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.91(t, J=6.6Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.8Hz, 1H), 2.70(d, J=5.2Hz, 1H), 3.80〜3.83(m, 1H), 5.05(t, J=5.0Hz, 1H), 7.24〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.26〜1.55(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.6Hz, 1H), 3.78〜3.84(m, 1H), 5.04(t, J=3.2Hz, 1H), 7.24〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.22(d, J=6.4Hz, 3H), 2.10(d, J=4.4Hz, 1H), 2.71(d, J=4.8Hz, 1H), 3.90〜3.95(m, 1H), 4.94(t, J=5.0Hz, 1H), 7.31(dd, J=2.0Hz, J=8.0Hz, 1H), 7.40(d, J=2.0Hz, 1H), 7.49(d, J=8.4Hz, 1H)
1H NMR(400MHz, CDCl3) δ1.22(d, J=6.4Hz, 3H), 2.10(d, J=4.4Hz, 1H), 2.71(d, J=4.8Hz, 1H), 3.90〜3.95(m, 1H), 4.94(t, J=5.0Hz, 1H), 7.31〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ1.22(d, J=6.4Hz, 3H), 2.10(d, J=4.4Hz, 1H), 2.71(d, J=4.8Hz, 1H), 3.90〜3.95(m, 1H), 4.94(t, J=5.0Hz, 1H), 7.31〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ1.02(t, J=7.4Hz, 3H), 1.54〜1.61(m, 2H), 2.07(d, J=4.8Hz, 1H), 2.74(d, J=4.8Hz, 1H), 3.65〜3.68(m, 1H), 5.01(t, J=5.0Hz, 1H), 7.31〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ1.02(t, J=7.4Hz, 3H), 1.54〜1.61(m, 2H), 2.07(d, J=4.8Hz, 1H), 2.74(d, J=4.8Hz, 1H), 3.65〜3.68(m, 1H), 5.01(t, J=5.0Hz, 1H), 7.31〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ1.02(t, J=7.4Hz, 3H), 1.54〜1.61(m, 2H), 2.07(d, J=4.8Hz, 1H), 2.74(d, J=4.8Hz, 1H), 3.65〜3.68(m, 1H), 5.01(t, J=5.0Hz, 1H), 7.31〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89〜0.93(m, 3H), 1.30〜1.39(m, 2H), 1.49〜1.52(m, 2H), 1.56〜1.62(m, 2H), 2.05(d, J=5.2Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.72〜3.77(m, 1H), 4.98(t, J=4.8Hz, 1H), 7.28〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89〜0.93(m, 3H), 1.30〜1.39(m, 2H), 1.49〜1.52(m, 2H), 1.56〜1.62(m, 2H), 2.05(d, J=5.2Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.72〜3.77(m, 1H), 4.98(t, J=4.8Hz, 1H), 7.28〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89〜0.93(m, 3H), 1.30〜1.39(m, 2H), 1.49〜1.52(m, 2H), 1.56〜1.62(m, 2H), 2.05(d, J=5.2Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.72〜3.77(m, 1H), 4.98(t, J=4.8Hz, 1H), 7.28〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜7.36(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜7.36(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜7.36(m, 3H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=7.6Hz, 3H), 1.26〜1.53(m, 2H), 2.64(dd, J=0.8Hz, J=4.0Hz, 1H), 3.14(d, J=8.4Hz, 1H), 4.22〜4.26(m, 1H), 5.26(t, J=8.4Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=7.6Hz, 3H), 1.26〜1.53(m, 2H), 2.64(dd, J=0.8Hz, J=4.0Hz, 1H), 3.14(d, J=8.4Hz, 1H), 4.22〜4.26(m, 1H), 5.26(t, J=8.4Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=7.6Hz, 3H), 1.26〜1.53(m, 2H), 2.64(dd, J=0.8Hz, J=4.0Hz, 1H), 3.14(d, J=8.4Hz, 1H), 4.22〜4.26(m, 1H), 5.26(t, J=8.4Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.8Hz, 6H), 1.60〜1.65(m, 1H), 2.35(d, J=4.0Hz, 1H), 3.12(d, J=8.4Hz, 1H), 4.13〜4.18(m, 1H), 5.36(t, J=7.6Hz, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=6.8Hz, 3H), 1.20〜1.31(m, 4H), 1.45〜1.53(m, 2H), 2.61〜2.62(m, 1H), 3.12(d, J=8.4Hz, 1H), 4.28〜4.33(m, 1H), 5.25(t, J=8.4Hz, 1H), 7.18〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=6.8Hz, 3H), 1.20〜1.31(m, 4H), 1.45〜1.53(m, 2H), 2.61〜2.62(m, 1H), 3.12(d, J=8.4Hz, 1H), 4.28〜4.33(m, 1H), 5.25(t, J=8.4Hz, 1H), 7.18〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=6.8Hz, 3H), 1.20〜1.31(m, 4H), 1.45〜1.53(m, 2H), 2.61〜2.62(m, 1H), 3.12(d, J=8.4Hz, 1H), 4.28〜4.33(m, 1H), 5.25(t, J=8.4Hz, 1H), 7.18〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ 3.59(d, J=5.2, 1H), 3.79(t, J=6.0, 3H), 5.59(d, J=5.2, 1H), 7.28〜7.43(m, 4H)
1H NMR(400MHz, CDCl3) δ3.23(s, 3H), 3.28(s, 3H), 4.33(d, J=6.0Hz, 1H), 5.81(d, J=5.6Hz, 1H), 7.23〜7.42(m, 4H)
1H NMR(400MHz, CDCl3) δ3.19(s, 3H), 3.42(s, 3H), 3.47(s, 3H), 4.75(d, J=6.8, 1H), 4.81(d, J=6.8, 1H), 6.07(s, 1H), 7.27〜7.58(m, 4H)
1H NMR(400MHz, CDCl3) δ2.18(s, 3H), 3.39(s, 3H), 4.65(d, J=6.8, 1H), 4.74(d, J=6.8, 1H), 5.63(s, 1H), 7.30〜7.45(m, 4H)
1H NMR(400MHz, CDCl3) δ1.13(d, J=6.4, 3H), 2.33(d, J=7.2, 1H), 3.44(s, 3H), 4.10〜4.18(m, 1H), 4.61(d, J=6.4, 1H), 4.69(d, J=6.8, 1H), 5.14(d, J=3.6, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(d, J=6.8, 3H), 2.01(d, J=5.6, 1H), 2.61(s, 1H), 4.21〜4.27(m, 1H), 5.24(d, J=3.6, 1H), 7.22〜7.64(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(d, J=6.8, 3H), 2.00(d, J=5.6, 1H), 2.54(d, J=3.6, 1H), 4.22〜4.26(m, 1H), 5.25(t, J=3.2, 1H), 7.22〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜 (m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜 (m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜(m, 3H)
1H NMR(400MHz, CDCl3) δ1.94(d, J=6.8Hz, 3H), 6.30〜6.38(m, 1H), 6.57(d, J=16Hz, 1H), 7.00〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.4Hz, 3H), 2.43(d, J=3.6Hz, 1H), 2.69(d, J=4.8Hz, 1H), 3.90〜3.98(m, 1H), 4.78(dd, J=4.4, 7.2Hz, 1H), 7.04〜7.50(m, 4H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.4Hz, 3H), 2.43(d, J=3.6Hz, 1H), 2.69(d, J=4.8Hz, 1H), 3.90〜3.98(m, 1H), 4.78(dd, J=4.4, 7.2Hz, 1H), 7.04〜7.50(m, 4H)
1H NMR(400MHz, CDCl3)δ7.30〜7.99(m, 4H), 10.10(s, 1H)
1H NMR(400MHz, CDCl3)δ1.95(dd, J=6.8Hz, 1.6Hz, 3H), 6.09〜6.18(m, 1H), 6.60(dd, J=15.66Hz, 1.8Hz, 1H), 6.89〜7.84(m, 4H)
1H NMR(400MHz, CDCl3)δ1.46(t, J=7.6Hz, 3H), 2.26〜2.34(m, 2H), 6.17(dt, J=15.6Hz, 6.6Hz 1H), 6.57(d, J=15.6Hz, 1H), 6.89〜7.85(m, 4H)
1H NMR(400MHz, CDCl3)δ1.27(d, J=6.4Hz, 3H), 2.26(br s, 1H), 2.74(br s, 1H), 3.99(t, J=6.0Hz, 1H), 4.81(d, J=4.0Hz, 1H), 7.01〜7.87(m, 4H)
1H NMR(400MHz, CDCl3)δ1.26(d, J=6.4Hz, 3H), 2.35(br s, 1H), 2.85(br d, J=4.0Hz, 1H), 3.98(t, J=6.2Hz, 1H), 4.80(dd, J=5.0, 4.4Hz, 1H), 7.00〜7.87(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 7.01〜7.87(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(t, J=7.4Hz, 3H), 1.52〜1.65(m, 2H), 2.01(d, J=4.4Hz, 1H), 2.74(d, J=5.2Hz, 1H), 3.69〜3.75(m, 1H), 5.05(t, J=5.0Hz, 1H), 7.03〜7.84(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=6.8Hz, 6H), 2.25〜2.57(m, 1H), 6.20(dd, J=16Hz, 7.2Hz, 1H), 7.64(d, J=16Hz, 1H), 7.04〜7.82(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.33〜1.56(m, 4H), 2.26〜2.32(m, 4H), 6.24(dt, J=15.6Hz, 7Hz, 1H), 6.78(d, J=16Hz, 1H), 7.12〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=7.6Hz, 3H), 2.29〜2.33(m, 2H), 6.28(dt, J=16Hz, 6.4Hz, 1H), 6.78(d, J=15.6Hz, 1H), 7.15〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=6.8Hz, 6H), 2.25〜2.57(m, 1H), 6.20(dd, J=16Hz, 7.2Hz, 1H), 7.64(d, J=16Hz, 1H), 7.11〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.33〜1.56(m, 4H), 2.26〜2.32(m, 4H), 6.24(dt, J=15.6Hz, 7Hz, 1H), 6.78(d, J=16Hz, 1H), 7.14〜7.52(m, 4H)
1H NMR(400MHz, CDCl3)δ1.95(dd, J=6.8Hz, 1.6Hz, 3H), 6.09〜6.18(m, 1H), 6.60(dd, J=15.66Hz, 1.8Hz, 1H), 6.87〜7.80(m, 4H)
1H NMR(400MHz, CDCl3)δ1.46(t, J=7.6Hz, 3H), 2.26〜2.34(m, 2H), 6.17(dt, J=15.6Hz, 6.6Hz 1H), 6.57(d, J=15.6Hz, 1H), 6.86〜7.81(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=6.8Hz, 6H), 2.25〜2.57(m, 1H), 6.20(dd, J=16Hz, 7.2Hz, 1H), 7.64(d, J=16Hz, 1H), 6.88〜7.64(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.33〜1.56(m, 4H), 2.26〜2.32(m, 4H), 6.24(dt, J=15.6Hz, 7Hz, 1H), 6.78(d, J=16Hz, 1H), 6.88〜7.59(m, 4H)
1H NMR(400MHz, CDCl3) δ1.94(d, J=6.8Hz, 3H), 6.30〜6.38(m, 1H), 6.57(d, J=16Hz, 1H), 6.85〜7.04(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=7.6Hz, 3H), 2.29〜2.33(m, 2H), 6.28(dt, J=16Hz, 6.4Hz, 1H), 6.78(d, J=15.6Hz, 1H), 6.88〜7.05(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J=6.8Hz, 6H), 2.25〜2.57(m, 1H), 6.20(dd, J=16Hz, 7.2Hz, 1H), 7.64(d, J=16Hz, 1H), 6.83〜7.09(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=7.2Hz, 3H), 1.33〜1.56(m, 4H), 2.26〜2.32(m, 4H), 6.24(dt, J=15.6Hz, 7Hz, 1H), 6.78(d, J=16Hz, 1H), 6.84〜7.07(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 7.04〜7.85(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 7.01〜7.87(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 7.02〜7.79(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 7.02〜7.79(m, 4H)
1H NMR(400MHz, CDCl3)δ1.27(d, J=6.4Hz, 3H), 2.26(br s, 1H), 2.74(br s, 1H), 3.99(t, J=6.0Hz, 1H), 4.81(d, J=4.0Hz, 1H), 6.98〜7.50(m, 4H)
1H NMR(400MHz, CDCl3)δ1.27(d, J=6.4Hz, 3H), 2.26(br s, 1H), 2.74(br s, 1H), 3.99(t, J=6.0Hz, 1H), 4.81(d, J=4.0Hz, 1H), 6.98〜7.50(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 6.99〜7.52(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 6.99〜7.52(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 6.92〜7.50(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 6.92〜7.50(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 6.95〜7.49(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 6.95〜7.49(m, 4H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.4Hz, 3H), 2.43(d, J=3.6Hz, 1H), 2.69(d, J=4.8Hz, 1H), 3.90〜3.98(m, 1H), 4.78(dd, J=4.4, 7.2Hz, 1H), 6.85〜7.04(m, 4H)
1H NMR(400MHz, CDCl3) δ1.15(d, J=6.4Hz, 3H), 2.43(d, J=3.6Hz, 1H), 2.69(d, J=4.8Hz, 1H), 3.90〜3.98(m, 1H), 4.78(dd, J=4.4, 7.2Hz, 1H), 6.85〜7.04(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 6.88〜7.05(m, 4H)
1H NMR(400MHz, CDCl3)δ1.04(t, J=7.6Hz, 3H), 1.60〜1.71(m, 2H), 2.07(br s, 1H), 2.74(br s, 1H), 3.71〜3.76(m, 1H), 4.87(d, J=4.8Hz, 1H), 6.88〜7.05(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 6.87〜7.02(m, 4H)
1H NMR(400MHz, CDCl3) δ1.07(t, J=7.2Hz, 6H), 1.83〜1.89(m, 1H), 1.92(d, J=5.6Hz, 1H), 2.69(d, J=6.4Hz, 1H), 3.53〜3.56(m, 1H), 5.22〜5.25(m, 1H), 6.87〜7.02(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 6.88〜7.09(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=7.2Hz, 3H), 1.35〜1.65(m, 6H), 2.08(d, J=4.4Hz, 1H), 2.71(d, J=5.2Hz, 1H), 3.78〜3.83(m, 1H), 5.04(t, J=5.0Hz, 1H), 6.88〜7.09(m, 4H)
M.P. 83〜84℃
1H NMR(400MHz, CDCl3) δ1.24(d, J=6.4Hz, 3H), 2.91(d, J=4.8Hz, 1H), 4.68(br s, 2H), 5.06〜5.09(m, 1H), 5.18〜5.21(m, 1H), 7.23〜7.55(m, 4H)
13C NMR(100MHz, CDCl3) δ16.4, 73.1, 75.0, 127.0, 128.4, 129.1, 129.5, 132.7, 138.0, 156.6
M.P. 85〜86℃
1H NMR(400MHz, CDCl3) δ1.24(d, J=6.4Hz, 3H), 2.98(d, J=4.0Hz, 1H), 4.73(br s, 2H), 5.04〜5.10(m, 1H), 5.18〜5.20(m, 1H), 7.24〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(d, J = 6.8Hz, 3H), 3.34(d, J = 3.2Hz, 1H), 5.06(brs, 2H), 5.09〜5.15(m, 1H), 5.31(br t, J = 2.4Hz, 1H), 7.18〜7.59(m, 4H)
1H NMR(400MHz, CDCl3) δ1.20(d, J=6.8, 3H), 2.68(s, 1H), 4.67(s, 2H), 5.16〜5.22(m, 1H), 5.36(t, J=3.2, 1H), 7.23〜7.61(m, 4H)
1H NMR(400MHz, CDCl3) δ1.20(d, J=6.4, 3H), 2.83(d, J=3.6, 1H), 4.78(s, 2H), 5.15〜5.21(m, 1H), 5.36(t, J=3.2, 1H), 7.23〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J = 7.4Hz, 3H), 1.57〜1.73(m, 2H), 3.01(d, J = 5.6Hz, 1H), 4.74(br s, 2H), 4.95(dt, J = 7.2, 8.8Hz, 1H), 5.23(t, J = 5.6Hz, 1H), 7.22〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.94(t, J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 2.92(s, 1H), 4.78(br s, 2H), 4.91〜4.96(m, 1H), 5.22(d, J=5.5Hz, 1H), 7.20〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.97(t, J=7Hz, 3H), 1.58〜1.74(m, 2H), 2.94(d, J=6Hz, 1H), 4.69(br s, 2H), 4.94〜4.99(m, 1H), 5.24(t, J=6Hz, 1H), 7.23〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(d, J = 6.4Hz, 3H), 1.09(d, J = 6.8Hz, 3H), 2.06(m, 1H), 2.75(d, J = 6.8Hz, 1H), 4.58(br s, 2H), 4.85〜4.88(m, 1H), 5.34〜5.37(m, 1H), 7.22〜7.33(m, 2H), 7.35〜7.37(m, 1H), 7.51〜7.53(m, 1H)
1H NMR(400MHz, CDCl3) δ1.01(d, J = 6.8Hz, 3H), 1.09(d, J = 6.8Hz, 3H), 2.06(m, 1H), 2.73(d, J = 6.8Hz, 1H), 4.57(br s, 2H), 4.85〜4.88(m, 1H), 5.34〜5.37(m, 1H), 7.24〜7.30(m, 2H), 7.35〜7.37(m, 1H), 7.51〜7.53(m, 1H)
1H NMR(400MHz, CDCl3) δ1.00(d, J=6.4Hz, 3H), 1.09(d, J=6.4Hz, 3H), 2.08(m, 1H), 2.76(d, J=6.0Hz, 1H), 4.59(br s, 2H), 4.87(dd, J=7.2Hz, 4.4Hz, 1H), 5.36(t, J=4.6, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ0.88(t, J = 7Hz, 3H), 1.33〜1.42(m, 4H), 1.53〜1.71(m, 2H), 2.89(d, J = 5.6Hz, 1H) 4.64(br s, 2H), 5.04(dt, J = 5.0, 9.0Hz, 1H), 5.20(t, J = 5.6Hz, 1H), 7.23〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.89(dd, J=5Hz, 3H), 1.28〜1.43(m, 4H), 1.52〜1.58(m, 1H), 1.65〜1.72(m, 1H), 2.90(d, J=6Hz, 1H), 4.64(br s, 2H), 5.01〜5.06(m, 1H), 5.22(t, J=6Hz, 1H), 7.22〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.88(dd, J=5Hz, 3H), 1.31〜1.43(m, 4H), 1.63〜1.70(m, 1H), 1.52〜1.60(m, 1H), 3.06(d, J=6Hz, 1H), 4.75(br s, 2H), 5.00〜5.05(m, 1H), 5.21(t, J=6Hz, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.03〜1.25(m, 3H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.20〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=6.8Hz, 3H), 1.20(d, J=5.96Hz, 3H), 1.49(dd, J=14.2Hz, 2H), 3.11(d, J=6.28Hz, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 7.22〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(dd, J=6.5Hz, 6H), 1.19(d, J=6.4Hz, 3H), 3.21(s, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.20〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 1.25(s, 3H), 2.56〜2.61(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.06〜1.40(m, 7H), 1.56〜1.61(m, 2H), 1.69〜1.71(m, 2H), 1.87〜1.94(m, 2H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.20〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.27(d, J=10Hz, 3H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.15〜7.56(m, 9H)
1H NMR(400MHz, CDCl3) δ1.08〜1.35(m, 9H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.20(d, J=6.8Hz, 3H), 2.80(d, J=4.8Hz, 3H), 3.20(d, J=4.4Hz, 1H), 4.75(br s, 1H), 5.03〜5.09(m, 1H), 5.14〜5.17(m, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ0.92(t, J=7.6Hz, 3H), 1.21(d, J=6.4Hz, 3H), 1.51(m, 2H), 3.09〜3.14(m, 2H), 3.28(d, J=4.4Hz, 1H), 4.82(br s, 1H), 5.03〜5.09(m, 1H), 5.14〜5.17(m, 1H), 7.22〜7.55(m. 4H)
1H NMR(400MHz, CDCl3) δ0.88〜1.16(m, 6H), 1.19〜1.26(m, 3H), 3.34(s, 1H), 3.71〜3.78(m, 1H), 4.62(br s, 1H), 5.03(t, J=5.8Hz, 1H), 5.13(d, J=4.9Hz, 1H), 7.20〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.49〜0.54(m, 2H), 0.74(d, J=7.2Hz, 2H), 1.22(s, 3H), 2.55〜2.60(m, 1H), 3.16(s, 1H), 5.00(s, 1H), 5.04〜5.11(m, 1H), 5.16(s, 1H), 7.23〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.05〜1.38(m, 8H), 1.58〜1.70(m, 3H), 1.85〜1.95(m, 2H), 3.39〜3.47(m, 1H), 3.56(s, 1H), 4.79(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.2Hz, 1H), 7.20〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.25(d, J=6Hz, 3H), 1.64(s, 1H), 3.13(d, J=4.4Hz, 1H), 4.37(d, J=5.6Hz, 2H), 5.12〜5.19(m, 2H), 7.23〜7.55(m, 9H)
1H NMR(400MHz, CDCl3) δ1.08〜1.35(m, 9H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.21(d, J=6Hz, 3H), 2.81(d, J=5Hz, 3H), 3.14(d, J=4Hz, 1H), 4.72(br s, 1H), 5.07(dd, J=6Hz, 1H), 5.16(t, J=6Hz, 1H), 7.22〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.92(t, J=7Hz, 3H), 1.21(d, J=6Hz, 3H), 1.53(dd, J=7Hz, 2H), 3.13(dd, J=7Hz, 2H), 3.28(d, 1H), 4.82(S, 1H), 5.06(dd, J=7Hz, 1H), 5.16(t, J=5Hz, 1H), 7.21〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.16(dd, J=6Hz, 6H), 1.21(d, J=6Hz, 3H), 3.23(d, J=6Hz, 1H), 3.75〜3.84(m, 1H), 4.61(br s, 1H), 5.06(t, J=6Hz, 1H), 5.16(t, J=6Hz, 1H), 7.22〜7.56(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.50(t, J=6Hz, 2H), 0.77(t, J=3Hz, 2H), 1.12(d, J=7Hz, 3H), 2.53〜2.59(m, 1H), 3.22(d, J=4Hz, 1H), 5.08(dd, J=6Hz, 1H), 5.15(S, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.07〜1.17(m, 3H), 1.21(d, J=6Hz, 3H), 1.29〜1.42(m, 3H), 1.72(dd, J=6Hz, 2H), 1.92(dd, J=6Hz, 2H), 3.26(d, J=4Hz, 1H), 3.46(t, J=4Hz, 1H), 4.68(d, J=6Hz, 1H), 5.07(dd, J=6Hz, 1H), 5.16(t, J=6Hz, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.25(d, J=6Hz, 3H), 3.16(d, J=4Hz, 1H), 4.36(d, J=6Hz, 2H), 5.14(dd, J=6Hz, 3H), 7.23〜7.56(m, 9H), 収率:19%(1.3g)
1H NMR(400MHz, CDCl3) δ1.08〜1.35(m, 9H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.22〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.22(d, J = 6.4Hz, 3H), 4.16(br t, 1H) 4.96(br t, 3H), 5.07(t, J = 4.8Hz, 1H), 7.23〜7.52(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.96(t, J = 7.4Hz, 3H), 1.58〜1.74(m, 2H), 2.98(d, J = 5.6Hz, 1H) 4.68(br s, 2H), 5.59(dt, J = 5.2, 8.8Hz, 1H), 5.19(t, J = 5.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.92(t, J = 7.4Hz, 3H), 1.30〜1.38(m, 1H), 1.57〜1.64(m, 1H), 3.74(d, J = 9.2Hz, 1H), 4.80(br s, 2H), 5.40〜5.50(m, 2H), 7.17〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.16〜7.33(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89(t, J = 3.6Hz, 3H), 1.28〜1.42(m, 4H), 1.52〜1.59(m, 1H), 1.64〜1.71(m, 1H), 2.98(d, J = 5.6Hz, 1H), 4.67(br s, 2H), 4.96〜5.00(m, 1H), 5.17(t, J = 5.6Hz, 1H), 7.30〜7.49(m 3H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.22(d, J = 6.4Hz, 3H), 4.16(br t, 1H) 4.96(br t, 3H), 5.07(t, J = 4.8Hz, 1H), 7.23〜7.52(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.96(t, J = 7.4Hz, 3H), 1.58〜1.74(m, 2H), 2.98(d, J = 5.6Hz, 1H) 4.68(br s, 2H), 5.59(dt, J = 5.2, 8.8Hz, 1H), 5.19(t, J = 5.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.92(t, J = 7.4Hz, 3H), 1.30〜1.38(m, 1H), 1.57〜1.64(m, 1H), 3.74(d, J = 9.2Hz, 1H), 4.80(br s, 2H), 5.40〜5.50(m, 2H), 7.17〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.16〜7.33(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89(t, J = 3.6Hz, 3H), 1.28〜1.42(m, 4H), 1.52〜1.59(m, 1H), 1.64〜1.71(m, 1H), 2.98(d, J = 5.6Hz, 1H), 4.67(br s, 2H), 4.96〜5.00(m, 1H), 5.17(t, J = 5.6Hz, 1H), 7.30〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.22(d, J = 6.4Hz, 3H), 4.16(br t, 1H) 4.96(br t, 3H), 5.07(t, J = 4.8Hz, 1H), 7.23〜7.52(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.96(t, J = 7.4Hz, 3H), 1.58〜1.74(m, 2H), 2.98(d, J = 5.6Hz, 1H) 4.68(br s, 2H), 5.59(dt, J = 5.2, 8.8Hz, 1H), 5.19(t, J = 5.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.92(t, J = 7.4Hz, 3H), 1.30〜1.38(m, 1H), 1.57〜1.64(m, 1H), 3.74(d, J = 9.2Hz, 1H), 4.80(br s, 2H), 5.40〜5.50(m, 2H), 7.17〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 7.16〜7.33(m, 3H)
1H NMR(400MHz, CDCl3) δ0.89(t, J = 3.6Hz, 3H), 1.28〜1.42(m, 4H), 1.52〜1.59(m, 1H), 1.64〜1.71(m, 1H), 2.98(d, J = 5.6Hz, 1H), 4.67(br s, 2H), 4.96〜5.00(m, 1H), 5.17(t, J = 5.6Hz, 1H), 7.30〜7.49(m, 3H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 7.17〜7.35(m, 3H)
1H NMR(400MHz, CDCl3) δ1.19(d, J=5.2Hz, 3H), 2.93(d, J=4.4Hz, 1H), 4.71(br s, 2H), 4.99〜5.06(m, H), 7.04〜7.48(m, 4H)
1H NMR(400MHz, CDCl3) δ1.19(d, J=5.2Hz, 3H), 2.93(d, J=4.4Hz, 1H), 4.71(br s, 2H), 4.99〜5.06(m, H), 7.04〜7.48(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 7.00〜7.76(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 2.95(d, J=3.6Hz, 1H), 4.73(br s, 2H), 5.01〜5.11(m, 2H), 7.01〜7.86(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 7.00〜7.76(m, 4H)
1H NMR(400MHz, CDCl3) δ1.24(d, J = 6.8Hz, 3H), 2.13(d, J = 4.4Hz, 1H), 4.12〜4.16(m, 1H), 4.85(br s, 2H), 5.98(d, J = 5.6Hz, 1H), 7.24〜7.43(m, 4H)
1H NMR(400MHz, CDCl3) δ1.24(d, J = 6.4Hz, 3H), 2.04(d, J = 4.8Hz, 1H), 4.11〜4.18(m, 1H), 4.74(br s, 2H), 6.00(d, J = 5.6Hz, 1H), 7.24〜7.43(m, 4H)
1H NMR(400MHz, CDCl3) δ1.24(d, J = 6.4Hz, 3H), 2.04(d, J = 4.8Hz, 1H), 4.11〜4.18(m, 1H), 4.74(br s, 2H), 6.00(d, J = 5.6Hz, 1H), 7.24〜7.43(m, 4H)
1H NMR(400MHz, CDCl3) δ1.21(d, J=6.4Hz, 3H), 2.80(d, J=4.8Hz, 3H), 3.12(s, 1H), 4.09〜4.16(m, 1H), 4.86(br s, 1H), 5.99(d, J= 6.0Hz, 1H), 7.23〜7.40(m, 4H)
1H NMR(400MHz, CDCl3) δ1.21(d, J=6.4Hz, 3H), 2.80(d, J=4.8Hz, 3H), 3.12(s, 1H), 4.09〜4.16(m, 1H), 4.86(br s, 1H), 5.99(d, J= 6.0Hz, 1H), 7.23〜7.40(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.22(d, J=6Hz, 3H), 2.15(d, J=4Hz, 1H), 2.81(d, J=5Hz, 3H), 4.12(dd, J=6Hz, 1H), 4.83(br s, 1H), 6.00(d, J=6Hz, 1H), 7.23〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.91(t, J=7Hz, 3H), 1.22(d, J=6Hz, 3H), 1.52(dd, J=7Hz, 2H), 2.23(d, J=4Hz, 1H), 3.09〜3.21(m, 2H), 4.09〜4.17(m, 1H), 4.93(s, 1H), 5.99(d, J=6Hz, 1H), 7.23〜7.47(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.91(t, J=7Hz, 3H), 1.22(d, J=6Hz, 3H), 1.52(dd, J=7Hz, 2H), 2.23(d, J=4Hz, 1H), 3.09〜3.21(m, 2H), 4.09〜4.17(m, 1H), 4.93(s, 1H), 5.99(d, J=6Hz, 1H), 7.23〜7.47(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.91(t, J=7Hz, 3H), 1.22(d, J=6Hz, 3H), 1.52(dd, J=7Hz, 2H), 2.23(d, J=4Hz, 1H), 3.09〜3.21(m, 2H), 4.09〜4.17(m, 1H), 4.93(s, 1H), 5.99(d, J=6Hz, 1H), 7.23〜7.47(m, 4H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.0Hz, 3H), 1.15〜1.19(m, 6H), 2.41(s, 1H), 3.76〜4.08(m, 1H), 4.34(s, 1H), 4.83(br s 1H), 5.95(d, J=5.3Hz, 1H), 7.19〜7.39(m, 4H)
1H NMR(400MHz, CDCl3) δ1.13(d, J=6Hz, 3H), 1.20(dd, J=9.2Hz, 6H), 2.23(s, 1H), 3.77〜3.82(m, 1H), 4.10(s, 1H), 4.76(br s, 1H), 5.98(d, J=5.6Hz, 1H), 7.23〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.14(d, J=6Hz, 3H), 1.21(dd, J=6Hz, 6H), 2.16(d, J=5Hz, 1H), 3.81(t, J=6Hz, 1H), 4.11(d, J=5Hz, 1H), 4.73(br s, 1H), 5.98(d, J=5Hz, 1H), 7.24〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ0.53〜0.60(m, 2H), 0.74(s, 2H), 1.21(d, J=6.0Hz, 3H), 2.19(s, 1H), 2.59(s, 1H), 4.11〜4.15(m, 1H), 5.13(br s, 1H), 5.99(d, J=5.20Hz, 1H), 7.23〜7.40(m, 4H)
1H NMR(400MHz, CDCl3) δ0.53〜0.60(m, 2H), 0.74(s, 2H), 1.21(d, J=6.0Hz, 3H), 2.19(s, 1H), 2.59(s, 1H), 4.11〜4.15(m, 1H), 5.13(br s, 1H), 5.99(d, J=5.20Hz, 1H), 7.23〜7.40(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.71(s, 2H), 1.19(d, J=6Hz, 3H), 2.45(S, 1H), 2.57(S, 1H), 4.08〜4.12(m, 1H), 5.26(s, 1H), 5.97(d, J=4Hz, 1H), 7.22〜7.54(m, 4H)
1H NMR(400MHz, CDCl3) δ1.10〜1.39(m, 7H), 1.61(s, 3H), 1.71〜1.74(m, 2H), 1.87(d, J=11.2Hz, 1H), 2.48(d, J=10.8Hz, 1H), 3.46(t, J=4Hz, 1H), 4.10〜4.11(m, 1H), 4.80(br s 1H), 5.97(d, J=5.6Hz, 1H), 7.23〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ1.10〜1.39(m, 7H), 1.61(s, 3H), 1.71〜1.74(m, 2H), 1.87(d, J=11.2Hz, 1H), 2.48(d, J=10.8Hz, 1H), 3.46(t, J=4Hz, 1H), 4.10〜4.11(m, 1H), 4.80(br s 1H), 5.97(d, J=5.6Hz, 1H), 7.23〜7.41(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.12〜1.19(m, 3H), 1.22(d, J=6Hz, 3H), 1.27〜1.37(m, 1H), 1.71(t, J=6Hz, 2H), 1.86〜1.88(m, 1H), 1.97〜2.00(m, 1H), 2.18(d, J=4Hz, 1H), 3.47(S, 1H), 4.12(t, J=6Hz, 1H), 4.78(S, 1H), 5.97(d, J=6Hz, 1H), 7.23〜7.40(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.23(d, J=6Hz, 3H), 2.16(d, J=4Hz, 1H), 4.12(t, J=6Hz, 1H), 4.31〜4.44(m, 2H), 5.22(br S, 1H), 6.04(d, J=6Hz, 1H), 7.27〜7.42(m, 9H)
1H NMR(400MHz, CDCl3) δ 1.23(d, J=6Hz, 3H), 2.16(d, J=4Hz, 1H), 4.12(t, J=6Hz, 1H), 4.31〜4.44(m, 2H), 5.22(br S, 1H), 6.04(d, J=6Hz, 1H), 7.27〜7.42(m, 9H)
1H NMR(400MHz, CDCl3) δ 1.23(d, J=6Hz, 3H), 2.16(d, J=4Hz, 1H), 4.12(t, J=6Hz, 1H), 4.31〜4.44(m, 2H), 5.22(br S, 1H), 6.04(d, J=6Hz, 1H), 7.27〜7.42(m, 9H)
1H NMR(400MHz, CDCl3) δ1.13(d, J = 6.8Hz, 3H), 2.49(d, J = 4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J = 8.8Hz, 1H), 7.30(d, J=8.4Hz, 1H), 7.39(d, J=2.0Hz, 2H), 7.50(dd, J=8.4Hz, 2.0Hz, 1H)
1H NMR(400MHz, CDCl3) δ1.13(d, J = 6.8Hz, 3H), 2.49(d, J = 4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J = 8.8Hz, 1H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J = 7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J = 6.0Hz, 1H), 5.91(d, J = 8.8Hz, 1H), 6.4(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J = 7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.4(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J=4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J=8.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J = 7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J = 4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J=8.4Hz, 1H), 7.16〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ1.13(d, J=6.8Hz, 3H), 2.49(d, J=4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J=8.8Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.13(d, J = 6.8Hz, 3H), 2.49(d, J = 4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J = 8.8Hz, 1H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J = 7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J = 6.0Hz, 1H), 5.91(d, J = 8.8Hz, 1H), 6.4(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J = 7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J = 6.0Hz, 1H), 5.91(d, J = 8.8Hz, 1H), 6.4(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J=4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J=8.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J = 7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J = 4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J = 8.4Hz, 1H), 7.16〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ1.13(d, J=6.8Hz, 3H), 2.49(d, J=4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J=8.8Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.13(d, J = 6.8Hz, 3H), 2.49(d, J = 4.0Hz, 1H), 4.66〜4.74(m, 1H), 4.76(br s, 2H), 6.20(d, J = 8.8Hz, 1H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J=7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.4(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.77(t, J = 7.4Hz, 3H), 0.92〜1.01(m, 1H), 1.18〜1.28(m, 1H), 4.06〜4.13(m, 1H), 4.96(d, J = 6.0Hz, 1H), 5.91(d, J = 8.8Hz, 1H), 6.4(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.96(d, J=6.0Hz, 1H), 5.91(d, J=8.8Hz, 1H), 6.42(br s, 2H), 7.25〜7.40(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J=7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J=4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J=8.4Hz, 1H), 7.30〜7.50(m, 3H)
1H NMR(400MHz, CDCl3) δ0.85(t, J = 7.2Hz, 3H), 1.18〜1.33(m, 4H), 1.48〜1.55(m, 2H), 2.35(d, J = 4.4Hz, 1H), 4.45〜4.50(m, 1H), 4.76(br s, 2H), 6.21(d, J = 8.4Hz, 1H), 7.16〜7.34(m, 3H)
1H NMR(400MHz, CDCl3) δ0.97(d, J=6.4Hz, 6H), 2.36〜2.52(m, 1H), 3.34(s, 1H), 4.80(br s 2H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ1.03〜1.25(m, 3H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=6.8Hz, 3H), 1.20(d, J=5.96Hz, 3H), 1.49(dd, J=14.2Hz, 2H), 3.11(d, J=6.28Hz, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(dd, J=6.5Hz, 6H), 1.19(d, J=6.4Hz, 3H), 3.21(s, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.01〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 1.25(s, 3H), 2.56〜2.61(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 7.03〜7.64(m, 4H)
1H NMR(400MHz, CDCl3) δ1.06〜1.40(m, 7H), 1.56〜1.61(m, 2H), 1.69〜1.71(m, 2H), 1.87〜1.94(m, 2H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.27(d, J=10Hz, 3H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.05〜7.66(m, 9H)
1H NMR(400MHz, CDCl3) δ1.08〜1.35(m, 9H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.02〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ1.03〜1.25(m, 3H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 6.90〜7.50(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=6.8Hz, 3H), 1.20(d, J=5.96Hz, 3H), 1.49(dd, J=14.2Hz, 2H), 3.11(d, J=6.28Hz, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 6.99〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ1.14(dd, J=6.5Hz, 6H), 1.19(d, J=6.4Hz, 3H), 3.21(s, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.01〜7.62(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 1.25(s, 3H), 2.56〜2.61(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 7.01〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ1.06〜1.40(m, 7H), 1.56〜1.61(m, 2H), 1.69〜1.71(m, 2H), 1.87〜1.94(m, 2H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.00〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.27(d, J=10Hz, 3H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.01〜7.67(m, 9H)
1H NMR(400MHz, CDCl3) δ1.08〜1.35(m, 9H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.01〜7.66(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(d, J=6.4Hz, 3H), 1.56(m, 2H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.90(t, J=6.8Hz, 3H), 1.20(d, J=5.96Hz, 3H), 1.49(dd, J=14.2Hz, 2H), 1.57(m, 2H), 3.11(d, J=6.28Hz, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=6.8Hz, 3H), 1.14(dd, J=6.5Hz, 6H), 1.57(m, 2H), 3.21(s, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.01〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 0.96(t, J=6.8Hz, 3H), 1.25(m, 2H), 2.56〜2.61(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=6.8Hz, 3H), 1.06〜1.40(m, 7H), 1.56〜1.61(m, 2H), 1.69〜1.71(m, 2H), 1.87〜1.94(m, 2H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ 0.96(t, J=6.8Hz, 3H), 1.55〜1.62(m, 2H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.05〜7.66(m, 9H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=6.8Hz, 3H), 1.08〜1.35(m, 6H), 1.55〜1.62(m, 2H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.02〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(d, J=6.4Hz, 6H), 2.36〜2.52(m, 1H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=6.8Hz, 3H), 1.10(d, J=6.4Hz, 6H), 1.49(dd, J=14.2Hz, 2H), 2.38〜2.42(m, 1H), 3.11(d, J=6.28Hz, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(d, J=6.8Hz, 6H), 1.14(d, J=6.5Hz, 6H), 2.39〜2.47(m, 1H), 3.90〜3.98(m, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.01〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 1.01(d, J=6.8Hz, 6H), 2.38〜2.44(m, 1H), 2.56〜2.61(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ1.01(d, J=6.8Hz, 6H), 1.11〜1.21(m, 4H), 1.47〜1.49(m, 4H), 1.69〜1.71(m, 2H), 2.38〜2.44(m, 1H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.10 (d, J=6.8Hz, 3H), 2.42(m, 1H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.05〜7.66(m, 9H)
1H NMR(400MHz, CDCl3) δ1.01(d, J=6.8Hz, 6H), 1.08〜1.35(m, 6H), 1.55〜1.62(m, 2H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.42(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.02〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=6.4Hz, 3H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 2.76(s, 3H), 3.34(s, 1H), 4.80(br s 1H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t, J=6.8Hz, 3H), 0.97(t, J=6.4Hz, 3H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 1.55〜1.60(m, 2H), 2.96(t, J= 6.0, 2H), 3.34(s, 1H), 4.84(br s, 1H), 5.05(t, J=5.88Hz, 1H), 5.14(s, 1H), 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=6.4Hz, 3H), 1.14(d, J=6.5Hz, 6H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 3.90〜3.98(m, 1H), 3.73〜3.82(m, 1H), 4.59(br s, 1H), 5.01〜5.07(m, 1H), 5.14(t, J=5.8Hz, 1H), 7.01〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.50〜0.56(m, 2H), 0.74(d, J=7.21Hz, 2H), 0.97(t, J=6.4Hz, 3H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 2.38〜2.44(m, 1H), 3.72(s, 1H), 4.98(br s, 1H), 5.05〜5.11(m, 1H), 7.16(s, 1H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=6.4Hz, 3H), 1.11〜1.21(m, 4H), 1.29〜1.33(m, 4H), 1.47〜1.49(m, 4H), 1.53(m, 2H), 1.69〜1.71(m, 2H), 3.19(d, J=4.32Hz, 1H), 3.45(s, 1H), 4.64(br s 1H), 5.02〜5.07(m, 1H), 5.14(t, J=6.08Hz, 1H) 7.02〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=6.4Hz, 3H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 3.12(d, J=5Hz, 1H), 4.37(d, J=6Hz, 2H), 5.12〜5.19(m, 3H), 7.05〜7.66(m, 9H)
1H NMR(400MHz, CDCl3) δ0.97(t, J=6.4Hz, 3H), 1.08〜1.35(m, 6H), 1.29〜1.33(m, 4H), 1.53(m, 2H), 1.55〜1.62(m, 2H), 1.65(br s, 1H), 1.75〜1.71(m, 1H), 2.14〜2.24(m, 1H), 2.27〜2.30(m, 1H), 3.23〜3.29(m, 1H), 3.47〜3.52(m, 1H), 4.67(br s, 1H), 5.01〜5.09(m, 1H), 5.12〜5.18(m, 1H), 7.02〜7.65(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.92〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 6.97〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 7.01〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.89〜7.05(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.92〜7.09(m, 4H)
1H NMR(400MHz, CDCl3) δ δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 6.94〜7.03(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 6.95〜7.17(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 7.00〜7.76(m, 4H)
1H NMR(400MHz, CDCl3) δ0.97(d, J=6.4Hz, 6H), 2.36〜2.52(m, 1H), 3.34(s, 1H), 4.80(br s 2H), 5.04(t, J=12.5Hz, 1H), 5.14(s, 1H), 7.01〜7.63(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 6.99〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.27(d, J=6.4Hz, 3H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 7.00〜7.22(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.92〜7.20(m, 4H)
1H NMR(400MHz, CDCl3) δ δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 6.92〜7.20(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J = 7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J = 10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 6.95〜7.21(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.96〜7.57(m, 4H)
1H NMR(400MHz, CDCl3) δ0.96(t. J=7.4Hz, 3H), 1.53〜1.73(m, 2H), 3.09(br s, 1H), 4.83(br s, 2H), 5.00〜5.10(m, 2H), 6.92〜7.51(m, 4H)
1H NMR(400MHz, CDCl3) δ δ1.00(t, J = 7.2Hz, 6H), 1.73〜1.79(m, 1H), 3.67〜3.69(m, 1H), 4.85(br s, 2H), 5.40〜5.43(m, 1H), 5.49〜5.54(m, 1H), 6.97〜7.53(m, 4H)
1H NMR(400MHz, CDCl3) δ0.84(t, J=7.0Hz, 3H), 1.20〜1.35(m, 4H), 1.36〜1.41(m, 1H), 1.59〜1.63(m, 1H), 3.71(d, J=10.0Hz, 1H), 4.74(br s, 2H), 5.40〜5.44(m, 1H), 5.52〜5.57(m, 1H), 7.01〜7.55(m, 4H)
1H NMR(400MHz, CDCl3) δ1.95(dd, J=6.8Hz, 1.6Hz, 3H), 6.24(m, 1H), 6.72(d, J=15.6Hz, 1H), 7.18〜7.44(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.18〜7.36(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J = 9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ1.95(dd, J=6.8Hz, 1.6Hz, 3H), 6.24(m, 1H), 6.72(d, J=15.6Hz, 1H), 7.09〜7.25(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.14〜7.26(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J=9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.18〜7.22(m, 3H)
1H NMR(400MHz, CDCl3) δ1.10(d, J=6.4Hz, 3H), 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 5.24(t, J=8.8Hz, 1H), 7.14〜7.26(m, 3H)
1H NMR(400MHz, CDCl3) δ1.15(d, J = 6.4Hz, 3H), 3.66(d, J=9.2Hz, 1H), 4.73(br s, 2H), 5.43(t, J = 9.0Hz, 1H), 5.62〜5.69(m, 1H), 7.13〜7.25(m, 3H)
1H NMR(400MHz, CDCl3) δ 2.72(d, J=2.4Hz, 1H), 3.10(d, J=8.4Hz, 1H), 4.47〜4.54(m, 1H), 4.91(t, J=8.8Hz, 1H), 7.09〜7.26(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.72(br s, 1H), 4.26(dd, J=12.0, 7.8Hz, 1H), 4.39(dd, J=12.0, 2.7Hz, 1H), 4.41(dd, J=7.8, 2.7Hz, 1H), 4.77(br 2H), 7.26〜7.68(m, 4H)
1H NMR(400MHz, CDCl3) δ5.34(dd, J=10.8, 0.8Hz, 1H), 5.65(dd, J=17.2, 0.8Hz, 1H), 6.89〜7.92(m, 5H)
1H NMR(400MHz, CDCl3) δ 2.07〜2.13(m, 1H), 3.52〜3.58(m, 1H), 3.89〜3.94(m, 1H), 5.04〜5.08(m, 1H), 7.01〜7.85(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.72(br s, 1H), 4.26(dd, J=12.0, 7.8Hz, 1H), 4.39(dd, J=12.0, 2.7Hz, 1H), 4.41(dd, J=7.8, 2.7Hz, 1H), 4.77(br 2H), 7.06〜7.29(m, 4H)
1H NMR(400MHz, CDCl3) δ5.34(dd, J=10.8, 0.8Hz, 1H), 5.65(dd, J=17.2, 0.8Hz, 1H), 6.92〜7.89(m, 5H)
1H NMR(400MHz, CDCl3) δ 2.07〜2.13(m, 1H), 3.52〜3.58(m, 1H), 3.89〜3.94(m, 1H), 5.04〜5.08(m, 1H), 6.90〜7.17(m, 4H)
1H NMR(400MHz, CDCl3) δ 1.72(br s, 1H), 4.26(dd, J=12.0, 7.8Hz, 1H), 4.39(dd, J=12.0, 2.7Hz, 1H), 4.41(dd, J=7.8, 2.7Hz, 1H), 4.77(br 2H), 7.01〜7.27(m, 4H)
1H NMR(400MHz, CDCl3) δ1.37(d, J=6.8 Hz, 3H), 3.30(s, 3H), 4.71(d, J=6.8, 1H), 4.82〜4.88(m, 1H), 5.45(s, 2H), 7.26〜7.70(m, 4H)
前記実施例1の方法により、下記の実施例2〜123の化合物を製造した。
V
1H NMR(400MHz, CDCl3) δ1.40(d, J=6.0Hz, 3H), 3.24(s, 3H), 4.71(d, J=6.4Hz, 1H), 4.80〜4.85(m, 1H), 7.01(br s, 1H), 7.07〜7.20(m, 4H)
前記実施例124の方法により、下記の実施例125〜246の化合物を製造した。
1H NMR(400MHz, DMSO-d6) δ1.12(d, J = 6.4Hz, 3H), 4.97〜5.03(m, 1H), 5.91(d, J = 5.2Hz, 1H), 6.31〜6.92(m, 4H), 7.30〜7.42(m, 4H)
前記実施例247の方法により、下記の実施例248〜256の化合物を製造した。
実験動物は、雄マウス(ICR)をオリエントバイオ(韓国)から購入し、1群あたり6匹を4−5日間適応させた。マウスの体重は19〜26グラムの範疇に属する動物を実験に用いた。試験物質の筋弛緩作用に対する薬理効果は、ロータロッド(Rotarod)試験、握力(Grip strength)試験、そして、筋力(wire hang)試験で評価した。すべてのマウスは、試験開始1時間前に試験環境に適応させた。すべての試験物質の薬効評価は、マウスの腹腔(10ul/g、bw)を通して評価した。
すべてのマウスは、試験前に一定に1分あたり15回転するロッド(rod)で5分間予め訓練をさせた。この時、5分の時間のうち最小2分間ロッド(rod)の上に留まることのできなかったマウスは試験から除外させた。すべての実験動物は訓練後45〜60分間休息を取らせた。薬物を投与する直前、もう一度さらに巻いた条件で回転するロッド(rod)で1分間訓練をさせたが、この時、ロッド(rod)から落ちたマウスは試験から除外させた。すべての試験物質は、試験を行う15分、30分、1時間、2時間前に腹腔(10ul/g、bw)に投与し、薬物の効果が最大の時間(通常15分、30分または60分)で有効濃度50%(ED50)の値を求めた。仮に、試験動物が試験終了時間までロッド(rod)に留まっていれば10分と記録した。評価のための試験時間は、最大10分を適用した。前記試験の結果は、下記の表3に示した。前記試験は、参考文献(Yasuda et. el. (2005) Antipyretic, analgesic and muscle relaxant activities of Pueraria isoflavonoids and their metabolites from Pueraria lobata Ohwi - a traditional Chinese drug. Biol. Pharm. Bull. 28: 1224-1228.)に記載された方法に従って行った。
前足を利用した握力(grip strength)試験は、実験動物の前足でつかみやすいように工夫された三角環が取り付けられた、ウゴバジレ(Ugo Basile)社で製作された機器を用いた(Ugo Basile、Model47106、Italy)。試験は投与前後に実施し、薬物の効果を評価した。すべての試験物質は、試験を行う15分、30分、1時間、2時間前に腹腔(10ul/g、bw)に投与し、薬物の効果が最大の時間(通常15分、30分または60分)で有効濃度50%(ED50)の値を求めた。試験は、マウスが前足で棒をつかむと、尻尾を引っ張ることで、つかんでいた棒を逃がす時点の力を記録した。この時、機器は力をグラムで表示する。すべてのマウスには、3回の試験の機会が与えられ、そのうちの最高値3つを選択し、その平均値を試験成績として用いた。試験の結果は、下記の表3に示した。前記試験は、参考文献(Nevins et. el. (1993) Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacol. 110: 92-96.)に記載された方法に従って行った。
やわらかい当て物が敷かれている床から約40センチメートル高さに30センチメートル長さの金属ワイヤを2本の柱の間に吊り下げて試験を行った。すべての試験物質は、試験を行う15分、30分、1時間、2時間前に腹腔(10ul/g、bw)に投与し、薬物の効果が最大の時間で有効濃度50%(ED50)の値を求めた。それぞれのマウスは、2本の前足を使ってワイヤをつかむようにし、この時からワイヤにしがみ付いてから当て物に落ちる時間を秒で記録した。各マウスは2分間隔で5回の機会が与えられ、最高記録3つを選択し、その平均値を試験成績として用いた。試験の結果は、表3に示した。前記試験は、参考文献(Jacqueline N. Crawley (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835: 18-26.)に記載された方法に従って行った。
Claims (8)
- 次の化合物からなる群より選択される化合物またはその薬学的に許容可能な塩。
1−(2−クロロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシプロピル−N−メチルカルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシプロピル−1−N−プロピルカルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−クロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−ヨードフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2−フルオロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2,4−ジクロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシプロピル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシブチル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシ−3−メチル−ブチル−1−カルバメート、
1−(2,6−ジクロロフェニル)−2−カルバモイルオキシヘキシル−1−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート
1−(2−クロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2,3−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−(R)−1−(メトキシメトキシ)−プロピル−(R)−2−カルバメート、
1−(2−クロロフェニル)−(S)−1−(メトキシメトキシ)−プロピル−(S)−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−クロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,3−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,4−ジクロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,5−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2,6−ジクロロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−フルオロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(4−フルオロフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2,6−ジフルオロフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−メチルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−プロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−イソプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−シクロプロピルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−シクロヘキシルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−ベンジルカルバメート、
1−(2−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−N−ビシクロ[2,2,1]ヘプタンカルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−プロピル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−3−メチル−ブチル−2−カルバメート、
1−(3−ヨードフェニル)−1−(メトキシメトキシ)−ヘキシル−2−カルバメート、
1−(2−クロロフェニル)−2−(メトキシメトキシ)−プロピル−1−カルバメート、および
1−(2−クロロフェニル)−2−(メトキシ)−プロピル−1−カルバメート。 - 前記化合物またはその薬学的に許容可能な塩は、ラセミ体、鏡像異性体、部分立体異性体、鏡像異性体の混合物、または部分立体異性体の混合物の形態である、請求項1〜3のいずれか1項に記載の化合物またはその薬学的に許容可能な塩。
- 請求項1〜3のいずれか1項に記載の化合物またはその薬学的に許容可能な塩、または前記化合物のラセミ体、鏡像異性体、部分立体異性体、鏡像異性体の混合物、または部分立体異性体の混合物を有効成分として含む、筋肉弛緩用、または筋肉攣縮関連疾病の治療または予防用薬学組成物。
- 前記筋肉攣縮関連疾病は、脊椎血管疾患、痙性脊髄麻痺、頸部脊椎症、脳性麻痺、外傷後遺症、および脊髄小脳変性症からなる群より選択されたものである、請求項5に記載の薬学組成物。
- 筋肉弛緩用の医薬品または筋肉攣縮関連疾病の治療もしくは予防のための医薬品の製造における、次の化学式1で表される化合物またはその薬学的に許容可能な塩の使用。
[化学式1]
Xは、ハロゲンであり、
nは、1〜5の整数であり、
R1は、C1〜C4の直鎖もしくは分枝鎖アルキル基であり、
Aは、化学式
Bは、C1〜C4の直鎖もしくは分枝鎖アルキル、およびC2〜C4のアルコキシアルキル基からなる群より選択されたものであり、
R 2 は、水素、C1〜C4の直鎖もしくは分枝鎖アルキル、C3〜C8のシクロアルキル基、およびベンジル基からなる群より選択されたものである。 - 前記筋肉攣縮関連疾病は、脊椎血管疾患、痙性脊髄麻痺、頸部脊椎症、脳性麻痺、外傷後遺症、および脊髄小脳変性症からなる群より選択されたものである、請求項7に記載の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161580409P | 2011-12-27 | 2011-12-27 | |
PCT/KR2012/011469 WO2013100566A1 (en) | 2011-12-27 | 2012-12-26 | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015506934A JP2015506934A (ja) | 2015-03-05 |
JP6155280B2 true JP6155280B2 (ja) | 2017-06-28 |
Family
ID=48655156
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014549996A Pending JP2015504055A (ja) | 2011-12-27 | 2012-12-26 | ルーゲーリッグ病の治療または予防に使用されるフェニルカルバメート化合物 |
JP2014549994A Pending JP2015504054A (ja) | 2011-12-27 | 2012-12-26 | 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物 |
JP2014549995A Active JP6298766B2 (ja) | 2011-12-27 | 2012-12-26 | てんかんの予防または治療に使用するためのフェニルカルバメート化合物 |
JP2014549993A Active JP6298765B2 (ja) | 2011-12-27 | 2012-12-26 | 脳卒中の治療または予防に使用されるするためのフェニルカルバメート化合物 |
JP2014549992A Active JP6089045B2 (ja) | 2011-12-27 | 2012-12-26 | 痛みの緩和または治療に使用するためのフェニルカルバメート化合物 |
JP2014549991A Active JP6155280B2 (ja) | 2011-12-27 | 2012-12-26 | フェニルアルキルカルバメート誘導体化合物およびこれを含む薬学組成物 |
JP2017141920A Pending JP2017193577A (ja) | 2011-12-27 | 2017-07-21 | てんかんの予防または治療に使用するためのフェニルカルバメート化合物 |
JP2018001648A Pending JP2018108996A (ja) | 2011-12-27 | 2018-01-10 | 脳卒中の治療または予防に使用するためのフェニルカルバメート化合物 |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014549996A Pending JP2015504055A (ja) | 2011-12-27 | 2012-12-26 | ルーゲーリッグ病の治療または予防に使用されるフェニルカルバメート化合物 |
JP2014549994A Pending JP2015504054A (ja) | 2011-12-27 | 2012-12-26 | 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物 |
JP2014549995A Active JP6298766B2 (ja) | 2011-12-27 | 2012-12-26 | てんかんの予防または治療に使用するためのフェニルカルバメート化合物 |
JP2014549993A Active JP6298765B2 (ja) | 2011-12-27 | 2012-12-26 | 脳卒中の治療または予防に使用されるするためのフェニルカルバメート化合物 |
JP2014549992A Active JP6089045B2 (ja) | 2011-12-27 | 2012-12-26 | 痛みの緩和または治療に使用するためのフェニルカルバメート化合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017141920A Pending JP2017193577A (ja) | 2011-12-27 | 2017-07-21 | てんかんの予防または治療に使用するためのフェニルカルバメート化合物 |
JP2018001648A Pending JP2018108996A (ja) | 2011-12-27 | 2018-01-10 | 脳卒中の治療または予防に使用するためのフェニルカルバメート化合物 |
Country Status (13)
Country | Link |
---|---|
US (6) | US20130203846A1 (ja) |
EP (6) | EP2797881B1 (ja) |
JP (8) | JP2015504055A (ja) |
KR (6) | KR101795563B1 (ja) |
CN (6) | CN104136413B (ja) |
AU (2) | AU2012360365B2 (ja) |
BR (2) | BR112014015482A8 (ja) |
CA (2) | CA2858977C (ja) |
ES (3) | ES2710902T3 (ja) |
IN (2) | IN2014MN01432A (ja) |
MX (2) | MX338554B (ja) |
RU (2) | RU2632659C2 (ja) |
WO (6) | WO2013100569A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
EP2797881B1 (en) * | 2011-12-27 | 2018-11-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
KR101717872B1 (ko) * | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물 |
EP2970109A4 (en) * | 2013-03-12 | 2017-01-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for neuroprotection comprising the same |
KR101792999B1 (ko) * | 2013-12-12 | 2017-11-02 | (주)바이오팜솔루션즈 | 간질 예방 또는 치료용 설파메이트 유도체 화합물 |
ES2704928T3 (es) * | 2013-12-12 | 2019-03-20 | Bio Pharm Solutions Co Ltd | Compuestos derivados de sulfamato para su uso en el tratamiento o alivio del dolor |
JP6807941B2 (ja) * | 2016-02-29 | 2021-01-06 | バイオ−ファーム ソリューションズ カンパニー リミテッド | スルファメート誘導体化合物、その製造方法および用途 |
EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
KR102005019B1 (ko) | 2018-04-04 | 2019-07-31 | 한국과학기술연구원 | 뇌졸중의 예방 및 치료용 조성물 |
WO2020010042A1 (en) | 2018-07-02 | 2020-01-09 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
US20210361318A1 (en) | 2018-07-02 | 2021-11-25 | Voyager Therapeutics, Inc. | Cannula system and use thereof |
KR102427769B1 (ko) | 2020-08-07 | 2022-08-02 | 한국과학기술연구원 | 다발성 경화증 예방 또는 치료용 조성물 |
KR102531540B1 (ko) | 2020-09-18 | 2023-05-16 | 한국과학기술연구원 | 류마티스 관절염 예방 또는 치료용 조성물 |
KR102614653B1 (ko) | 2021-06-09 | 2023-12-20 | 한국과학기술연구원 | 신규한 헤테로사이클릴-페닐-메틸아민 유도체, 이의 제조방법 및 이의 다발성 경화증 예방, 개선, 또는 치료 용도 |
KR102399807B1 (ko) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
EP4382509A1 (en) | 2021-08-05 | 2024-06-12 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate crystalline form and method for preparing same |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2884444A (en) | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
US2937119A (en) | 1959-06-11 | 1960-05-17 | Carter Prod Inc | Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates |
US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3313699A (en) * | 1962-06-26 | 1967-04-11 | Armour Pharma | Compositions for and method of treating the central nervous system |
US3265727A (en) | 1962-06-26 | 1966-08-09 | Armour Pharma | Phenyl alkyl-1, 2 dicarbamates |
US3313696A (en) | 1962-06-26 | 1967-04-11 | Armour Pharmacentical Company | Carbamate sedative compositions and method of use |
US3313700A (en) * | 1962-07-18 | 1967-04-11 | Armour Pharmacentical Company | Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor |
US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
FR5671M (ja) * | 1965-04-23 | 1968-01-02 | ||
US3600427A (en) | 1967-05-08 | 1971-08-17 | Anthony J Verbiscar | Phenyl carbamate latentiated phenethylamines |
JPS61271992A (ja) * | 1985-05-28 | 1986-12-02 | Central Glass Co Ltd | 光学活性ジオ−ルの製造方法 |
WO1994027941A1 (en) * | 1993-05-25 | 1994-12-08 | Avondale Chemical Company | Process for preparing felbamate and intermediates thereto |
US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US6242468B1 (en) * | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
DE60033050T2 (de) * | 1999-11-29 | 2007-11-15 | Mitsubishi Rayon Co., Ltd. | Acetalsulfonat-derivate, verfahren zu ihrer herstellung und verfahren zur herstellung eines styroloxid-derivats |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
HUP0303236A3 (en) | 2001-02-27 | 2012-07-30 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in the treatment of pain |
CN1235579C (zh) * | 2001-02-27 | 2006-01-11 | 奥索-麦克尼尔药品公司 | 用于预防或治疗神经变性疾病的氨基甲酸酯化合物 |
MXPA03008999A (es) | 2001-04-02 | 2004-02-12 | Astrazeneca Ab | Composicion farmaceutica solida que comprende 4-ciano -trifluor-3 -(4-fluorfenilsulfonil) -2-hidroxi-2 -metilpropino -m-toluidida y pvp. |
ATE373475T1 (de) | 2001-06-25 | 2007-10-15 | Sk Corp | Carbamate von 2-heterozyklischen 1,2-ethandiolen |
CA2454049A1 (en) | 2001-07-16 | 2003-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain |
EP2248799B1 (en) * | 2001-12-21 | 2015-05-20 | SK Biopharmaceuticals Co., LTD | Process for preparing 2-(substituted phenyl)-2-hydroxy-ethyl carbamates |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
WO2003101917A2 (en) | 2002-05-31 | 2003-12-11 | Sun Pharmaceutical Industries Limited | A process for the preparation of phenylcarbamates |
US6897217B2 (en) * | 2003-04-23 | 2005-05-24 | Schering Corporation | 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
WO2005044093A2 (en) | 2003-11-05 | 2005-05-19 | Unimed Pharmaceuticals, Inc. | Delta-9- the treatment of multiple sclerosis |
TW200538118A (en) * | 2004-04-21 | 2005-12-01 | Schering Corp | Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
NZ552336A (en) * | 2004-06-08 | 2010-12-24 | Families Of Spinal Muscular Atrophy | 2,4-Diaminoquinazolines for spinal muscular atrophy |
US20060194873A1 (en) * | 2004-09-16 | 2006-08-31 | Choi Yong M | Methods of treating epileptogenesis and epilepsy |
CN101076327A (zh) * | 2004-10-15 | 2007-11-21 | 詹森药业有限公司 | 用于治疗神经变性疾病的氨基甲酸酯化合物 |
US7442438B2 (en) | 2005-05-04 | 2008-10-28 | 3M Innovative Properties Company | Wet and dry stick adhesive, articles, and methods |
TW200800954A (en) | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
US7737141B2 (en) * | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
CN101472913A (zh) * | 2006-07-28 | 2009-07-01 | 卫材R&D管理有限公司 | 肉桂酰胺化合物的前药 |
EA200970355A1 (ru) * | 2006-10-06 | 2009-12-30 | Янссен Фармацевтика Нв | Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата |
EA200970378A1 (ru) * | 2006-10-13 | 2009-10-30 | Янссен Фармацевтика, Н. В. | Композиции фенилалкилкарбамата |
US20080103198A1 (en) | 2006-10-27 | 2008-05-01 | Haas Magali | Methods for treatment of cochlear and vestibular disorders |
CN101568362A (zh) | 2006-10-30 | 2009-10-28 | 詹森药业有限公司 | 治疗抑郁症的方法 |
PE20081775A1 (es) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | Compuestos macrociclicos como inhibidores del factor viia |
CA2683398A1 (en) * | 2007-04-10 | 2008-10-16 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
WO2009022345A1 (en) | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
US20090105498A1 (en) * | 2007-10-18 | 2009-04-23 | Porstmann Frank | Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates |
WO2010022300A1 (en) | 2008-08-21 | 2010-02-25 | Forest Laboratories Holdings Limited | Methods for treating neuropathic pain |
JP2011219387A (ja) * | 2010-04-06 | 2011-11-04 | Kaneka Corp | イオン液体の製造方法 |
CA2803825C (en) * | 2010-07-02 | 2015-12-29 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
CA2815460C (en) * | 2011-01-13 | 2017-04-18 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
CN103635472B (zh) * | 2011-02-28 | 2018-01-12 | 阵列生物制药公司 | 丝氨酸/苏氨酸激酶抑制剂 |
EP2797881B1 (en) * | 2011-12-27 | 2018-11-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
-
2012
- 2012-12-26 EP EP12863856.6A patent/EP2797881B1/en active Active
- 2012-12-26 EP EP12861408.8A patent/EP2797877A4/en not_active Withdrawn
- 2012-12-26 EP EP12862021.8A patent/EP2797878B1/en active Active
- 2012-12-26 ES ES12863856T patent/ES2710902T3/es active Active
- 2012-12-26 MX MX2014008021A patent/MX338554B/es active IP Right Grant
- 2012-12-26 KR KR1020147020773A patent/KR101795563B1/ko active IP Right Grant
- 2012-12-26 JP JP2014549996A patent/JP2015504055A/ja active Pending
- 2012-12-26 CA CA2858977A patent/CA2858977C/en active Active
- 2012-12-26 JP JP2014549994A patent/JP2015504054A/ja active Pending
- 2012-12-26 EP EP12862488.9A patent/EP2797880B1/en active Active
- 2012-12-26 CN CN201280070646.6A patent/CN104136413B/zh active Active
- 2012-12-26 WO PCT/KR2012/011472 patent/WO2013100569A1/en active Application Filing
- 2012-12-26 CN CN201280070782.5A patent/CN104136416B/zh active Active
- 2012-12-26 WO PCT/KR2012/011474 patent/WO2013100570A1/en active Application Filing
- 2012-12-26 ES ES12862332T patent/ES2716832T3/es active Active
- 2012-12-26 JP JP2014549995A patent/JP6298766B2/ja active Active
- 2012-12-26 WO PCT/KR2012/011470 patent/WO2013100567A1/en active Application Filing
- 2012-12-26 EP EP12862332.9A patent/EP2797879B1/en active Active
- 2012-12-26 CN CN201280070632.4A patent/CN104169253B/zh active Active
- 2012-12-26 KR KR1020147017115A patent/KR20140113918A/ko not_active Application Discontinuation
- 2012-12-26 CA CA2859129A patent/CA2859129C/en active Active
- 2012-12-26 RU RU2014124028A patent/RU2632659C2/ru active
- 2012-12-26 AU AU2012360365A patent/AU2012360365B2/en active Active
- 2012-12-26 EP EP12861302.3A patent/EP2797876A4/en not_active Withdrawn
- 2012-12-26 JP JP2014549993A patent/JP6298765B2/ja active Active
- 2012-12-26 AU AU2012360362A patent/AU2012360362B2/en active Active
- 2012-12-26 KR KR1020147016928A patent/KR101795562B1/ko active IP Right Grant
- 2012-12-26 BR BR112014015482A patent/BR112014015482A8/pt not_active Application Discontinuation
- 2012-12-26 KR KR1020147015403A patent/KR101880584B1/ko active IP Right Grant
- 2012-12-26 RU RU2014124029A patent/RU2014124029A/ru unknown
- 2012-12-26 MX MX2014008020A patent/MX353024B/es active IP Right Grant
- 2012-12-26 KR KR1020147017965A patent/KR101862203B1/ko active IP Right Grant
- 2012-12-26 WO PCT/KR2012/011469 patent/WO2013100566A1/en active Application Filing
- 2012-12-26 JP JP2014549992A patent/JP6089045B2/ja active Active
- 2012-12-26 ES ES12862488.9T patent/ES2624989T3/es active Active
- 2012-12-26 BR BR112014015568-2A patent/BR112014015568B1/pt active IP Right Grant
- 2012-12-26 CN CN201280070738.4A patent/CN104136415B/zh active Active
- 2012-12-26 WO PCT/KR2012/011475 patent/WO2013100571A1/en active Application Filing
- 2012-12-26 JP JP2014549991A patent/JP6155280B2/ja active Active
- 2012-12-26 CN CN201280070737.XA patent/CN104870421A/zh active Pending
- 2012-12-26 WO PCT/KR2012/011471 patent/WO2013100568A1/en active Application Filing
- 2012-12-26 KR KR1020147017116A patent/KR20140113919A/ko not_active Application Discontinuation
- 2012-12-26 CN CN201280070692.6A patent/CN104136414A/zh active Pending
- 2012-12-27 US US13/727,661 patent/US20130203846A1/en not_active Abandoned
- 2012-12-27 US US13/727,665 patent/US9034848B2/en active Active
- 2012-12-27 US US13/727,654 patent/US9624164B2/en active Active
- 2012-12-27 US US13/727,659 patent/US9029589B2/en active Active
- 2012-12-27 US US13/727,656 patent/US20130184338A1/en not_active Abandoned
- 2012-12-27 US US13/727,663 patent/US9162975B2/en active Active
-
2014
- 2014-07-15 IN IN1432MUN2014 patent/IN2014MN01432A/en unknown
- 2014-07-15 IN IN1436MUN2014 patent/IN2014MN01436A/en unknown
-
2017
- 2017-07-21 JP JP2017141920A patent/JP2017193577A/ja active Pending
-
2018
- 2018-01-10 JP JP2018001648A patent/JP2018108996A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6155280B2 (ja) | フェニルアルキルカルバメート誘導体化合物およびこれを含む薬学組成物 | |
JP5774694B2 (ja) | フェニルカルバメート化合物およびこれを含む筋肉弛緩剤 | |
JP5838226B2 (ja) | フェニルカルバメート誘導体の製造方法 | |
JP6200526B2 (ja) | 運動障害の予防又は治療用フェニルカルバメート化合物 | |
EP2238105B1 (en) | Novel compounds as vanilloid receptor antagonists | |
US20150133541A1 (en) | Phenylcarbamate compound and muscle relaxant containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151210 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160921 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161004 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170523 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170605 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6155280 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |